Endozepines and their receptors: Structure, functions and pathophysiological significance.

[1]  Paul R. Dobner,et al.  Neurotensin/Neuromedin N , 2020, Definitions.

[2]  A. Korshunov,et al.  Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation. , 2019, Cell metabolism.

[3]  S. Fulton,et al.  The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system. , 2019, The Journal of clinical investigation.

[4]  Connor D. Courtney,et al.  Differential impacts on multiple forms of spatial and contextual memory in diazepam binding inhibitor knockout mice , 2019, Journal of neuroscience research.

[5]  S. Becker,et al.  Translocator Protein Ligand Protects against Neurodegeneration in the MPTP Mouse Model of Parkinsonism , 2019, The Journal of Neuroscience.

[6]  T. Tencomnao,et al.  Phenotypic subgrouping and multi-omics analyses reveal reduced diazepam-binding inhibitor (DBI) protein levels in autism spectrum disorder with severe language impairment , 2019, PloS one.

[7]  F. Grassmann,et al.  The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia , 2019, Journal of Neuroinflammation.

[8]  T. Guilarte.  TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward. , 2019, Pharmacology & therapeutics.

[9]  H. Vaudry,et al.  Neuroprotection with the Endozepine Octadecaneuropeptide, ODN. , 2019, Current pharmaceutical design.

[10]  T. Tatlisumak,et al.  Astrocyte activation and reactive gliosis—A new target in stroke? , 2019, Neuroscience Letters.

[11]  M. Zonta,et al.  Dynamic interactions between GABAergic and astrocytic networks , 2019, Neuroscience Letters.

[12]  A. Araque,et al.  Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism , 2018, Nature Neuroscience.

[13]  H. Vaudry,et al.  Antioxidant and Anti-Apoptotic Activity of Octadecaneuropeptide Against 6-OHDA Toxicity in Cultured Rat Astrocytes , 2018, Journal of Molecular Neuroscience.

[14]  W. Sieghart,et al.  International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans , 2018, Pharmacological Reviews.

[15]  W. Jagust.  Imaging the evolution and pathophysiology of Alzheimer disease , 2018, Nature Reviews Neuroscience.

[16]  M. Korbonits,et al.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature , 2018, Pharmacological Reviews.

[17]  Connor D. Courtney,et al.  Subregion-Specific Impacts of Genetic Loss of Diazepam Binding Inhibitor on Synaptic Inhibition in the Murine Hippocampus , 2018, Neuroscience.

[18]  R. Banati,et al.  Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain , 2018, International journal of molecular sciences.

[19]  Qiang Xu,et al.  Apelin , 2018, Medicine.

[20]  M. Babu,et al.  Mechanisms of signalling and biased agonism in G protein-coupled receptors , 2018, Nature Reviews Molecular Cell Biology.

[21]  Zodwa Dlamini,et al.  Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers , 2018, International journal of molecular sciences.

[22]  A. Vejux,et al.  Induction of Neuronal Differentiation of Murine N2a Cells by Two Polyphenols Present in the Mediterranean Diet Mimicking Neurotrophins Activities: Resveratrol and Apigenin , 2018, Diseases.

[23]  Nir Qvit,et al.  Backbone-Cyclized Peptides: A Critical Review. , 2018, Current topics in medicinal chemistry.

[24]  P. Moreira,et al.  Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events , 2018, Front. Physiol..

[25]  E. Sigel,et al.  The Benzodiazepine Binding Sites of GABAA Receptors. , 2018, Trends in pharmacological sciences.

[26]  R. Olsen.  GABAA receptor: Positive and negative allosteric modulators , 2018, Neuropharmacology.

[27]  F. Gage,et al.  Human Adult Neurogenesis: Evidence and Remaining Questions. , 2018, Cell stem cell.

[28]  C. Claudianos,et al.  Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease , 2018, Front. Mol. Neurosci..

[29]  R. Franco,et al.  Redox Biology in Neurological Function, Dysfunction, and Aging. , 2018, Antioxidants & redox signaling.

[30]  M. Migaud,et al.  A comparative study of the neural stem cell niche in the adult hypothalamus of human, mouse, rat and gray mouse lemur (Microcebus murinus) , 2018, The Journal of comparative neurology.

[31]  Min Goo Lee,et al.  Unconventional protein secretion – new insights into the pathogenesis and therapeutic targets of human diseases , 2018, Journal of Cell Science.

[32]  A. Peier,et al.  Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges. , 2018, Bioorganic & medicinal chemistry.

[33]  Connor D. Courtney,et al.  Genetic loss of diazepam binding inhibitor in mice impairs social interest , 2018, Genes, brain, and behavior.

[34]  A. Sharif,et al.  The Versatile Tanycyte: A Hypothalamic Integrator of Reproduction and Energy Metabolism , 2018, Endocrine reviews.

[35]  H. Vaudry,et al.  Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival , 2018, Molecular Neurobiology.

[36]  S. Mandrup,et al.  Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson’s disease , 2018, Cellular and Molecular Life Sciences.

[37]  R. M. Walsh,et al.  Structure of a human synaptic GABA-A receptor , 2018, Nature.

[38]  R. Dantzer,et al.  Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorder , 2018, Psychoneuroendocrinology.

[39]  R. Seeley,et al.  Signalling from the periphery to the brain that regulates energy homeostasis , 2018, Nature Reviews Neuroscience.

[40]  K. Humphreys,et al.  Our Other Prescription Drug Problem. , 2018, The New England journal of medicine.

[41]  N. Revadigar,et al.  Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation , 2018, Therapeutic advances in psychopharmacology.

[42]  J. Swinny,et al.  Molecular Characterization of GABA-A Receptor Subunit Diversity within Major Peripheral Organs and Their Plasticity in Response to Early Life Psychosocial Stress , 2018, Front. Mol. Neurosci..

[43]  V. Papadopoulos,et al.  Translocator protein (18 kDa): an update on its function in steroidogenesis , 2018, Journal of neuroendocrinology.

[44]  V. Papadopoulos,et al.  CRISPR/Cas9[FIGURE DASH]Mediated Tspo Gene Mutations Lead to Reduced Mitochondrial Membrane Potential and Steroid Formation in MA-10 Mouse Tumor Leydig Cells , 2018, Endocrinology.

[45]  K. Zoltowska,et al.  Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects , 2018, Oxidative medicine and cellular longevity.

[46]  Meng Chen,et al.  Drugs targeting intermediate filaments can improve neurosupportive properties of astrocytes , 2018, Brain Research Bulletin.

[47]  T. Suhara,et al.  Steroidogenic abnormalities in translocator protein knockout mice and significance in the aging male. , 2018, The Biochemical journal.

[48]  X. Shu,et al.  Retinal pigment epithelium cholesterol efflux mediated by the 18 kDa translocator protein, TSPO, a potential target for treating age-related macular degeneration , 2017, Human molecular genetics.

[49]  P. Matthews,et al.  TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis , 2017, The Biochemical journal.

[50]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview , 2017, British journal of pharmacology.

[51]  D. Morin,et al.  A TSPO ligand prevents mitochondrial sterol accumulation and dysfunction during myocardial ischemia‐reperfusion in hypercholesterolemic rats , 2017, Biochemical pharmacology.

[52]  Akos Kulik,et al.  GABAergic Regulation of Adult Hippocampal Neurogenesis , 2016, Molecular Neurobiology.

[53]  H. Becker.  Influence of stress associated with chronic alcohol exposure on drinking , 2017, Neuropharmacology.

[54]  D. Richard,et al.  Emerging Signaling Pathway in Arcuate Feeding-Related Neurons: Role of the Acbd7 , 2017, Front. Neurosci..

[55]  D. Larhammar,et al.  The Arg–Phe‐amide peptide 26RFa/glutamine RF‐amide peptide and its receptor: IUPHAR Review 24 , 2017, British journal of pharmacology.

[56]  C. Heinis,et al.  Cyclic peptide therapeutics: past, present and future. , 2017, Current opinion in chemical biology.

[57]  J. Rees,et al.  Significant up-regulation of 1-ACBP, B-ACBP and PBR genes in immune cells within the oesophageal malignant tissue and a possible link in carcinogenic angiogenesis. , 2017, Histology and histopathology.

[58]  A. Jean,et al.  Glial Endozepines Inhibit Feeding-Related Autonomic Functions by Acting at the Brainstem Level , 2017, Front. Neurosci..

[59]  H. Monyer,et al.  Diazepam Binding Inhibitor Promotes Stem Cell Expansion Controlling Environment-Dependent Neurogenesis , 2017, Neuron.

[60]  S. Becker,et al.  Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure , 2017, Nature Communications.

[61]  J. Chuquet,et al.  Investigations of octylglyceryl dextran-graft-poly(lactic acid) nanoparticles for peptide delivery to the brain. , 2017, Nanomedicine.

[62]  A. Merrill,et al.  Regulation of very-long acyl chain ceramide synthesis by acyl-CoA-binding protein , 2017, The Journal of Biological Chemistry.

[63]  S. Thompson,et al.  A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice , 2017, eNeuro.

[64]  A. Prat,et al.  The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin/Kexin 9 , 2017, Pharmacological Reviews.

[65]  Howard An,et al.  Flumazenil in benzodiazepine overdose , 2016, Canadian Medical Association Journal.

[66]  M. Skiba,et al.  To what extent is it possible to dissociate the anxiolytic and sedative/hypnotic properties of GABAA receptors modulators? , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[67]  V. Papadopoulos,et al.  Plasma Membrane Origin of the Steroidogenic Pool of Cholesterol Used in Hormone-induced Acute Steroid Formation in Leydig Cells* , 2016, The Journal of Biological Chemistry.

[68]  S. Fulton,et al.  DBI/ACBP loss-of-function does not affect anxiety-like behaviour but reduces anxiolytic responses to diazepam in mice , 2016, Behavioural Brain Research.

[69]  P. Puigserver,et al.  PGC-1 Coactivators: Shepherding the Mitochondrial Biogenesis of Tumors. , 2016, Trends in cancer.

[70]  C. Kahn,et al.  Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability , 2016, Cell.

[71]  M. Pekny,et al.  Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress , 2016, Molecular Neurobiology.

[72]  P. Tufféry,et al.  Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery , 2016, Expert opinion on drug discovery.

[73]  G. Ecker,et al.  Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What? , 2016, Front. Mol. Neurosci..

[74]  G. Pelletier,et al.  Increased Hypothalamic Levels of Endozepines, Endogenous Ligands of Benzodiazepine Receptors, in a Rat Model of Sepsis , 2016, Shock.

[75]  L. Kuhn,et al.  Translocator Protein 18 kDa (TSPO): An Old Protein with New Functions? , 2016, Biochemistry.

[76]  C. A. Masuda,et al.  The ACBP gene family in Rhodnius prolixus: Expression, characterization and function of RpACBP-1. , 2016, Insect biochemistry and molecular biology.

[77]  D. Morin,et al.  Mitochondrial translocator protein (TSPO): From physiology to cardioprotection. , 2016, Biochemical pharmacology.

[78]  M. Sofroniew,et al.  Astrocytes: a central element in neurological diseases , 2016, Acta Neuropathologica.

[79]  M. Laplante,et al.  Involvement of the Acyl-CoA binding domain containing 7 in the control of food intake and energy expenditure in mice , 2016, eLife.

[80]  H. Vaudry,et al.  Comparative aspects of neurosteroidogenesis: From fish to mammals. , 2016, General and comparative endocrinology.

[81]  Michael T. Heneka,et al.  Translocator protein and new targets for neuroinflammation , 2015, Clinical and Translational Imaging.

[82]  H. F. Carvalho,et al.  n-3 Fatty Acids Induce Neurogenesis of Predominantly POMC-Expressing Cells in the Hypothalamus , 2015, Diabetes.

[83]  G. Kim,et al.  The Role of Oxidative Stress in Neurodegenerative Diseases , 2015, Experimental neurobiology.

[84]  H. Vaudry,et al.  Octadecaneuropeptide ODN prevents hydrogen peroxide-induced oxidative damage of biomolecules in cultured rat astrocytes , 2015, Peptides.

[85]  V. Papadopoulos,et al.  Computational modeling and biological validation of novel non-steroidal ligands for the cholesterol recognition/interaction amino acid consensus (CRAC) motif of the mitochondrial translocator protein (TSPO). , 2015, Pharmacological research.

[86]  V. Papadopoulos,et al.  2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[87]  S. Becker,et al.  Structure of the mammalian TSPO/PBR protein. , 2015, Biochemical Society transactions.

[88]  V. Papadopoulos,et al.  Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis , 2015, Molecular and Cellular Endocrinology.

[89]  V. Papadopoulos,et al.  Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation , 2015, Proceedings of the National Academy of Sciences.

[90]  Evelyn M. R. Lake,et al.  The Effects of Delayed Reduction of Tonic Inhibition on Ischemic Lesion and Sensorimotor Function , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[91]  N. Færgeman,et al.  Long-chain acyl-CoA esters in metabolism and signaling: Role of acyl-CoA binding proteins. , 2015, Progress in lipid research.

[92]  J. Chuquet,et al.  Detection, characterization and biological activities of [bisphospho-thr3,9]ODN, an endogenous molecular form of ODN released by astrocytes , 2015, Neuroscience.

[93]  S. Mandrup,et al.  A novel role for central ACBP/DBI as a regulator of long‐chain fatty acid metabolism in astrocytes , 2015, Journal of neurochemistry.

[94]  B. Birnir,et al.  GABAergic signalling in the immune system , 2015, Acta physiologica.

[95]  J. Argente,et al.  Role of Non-Neuronal Cells in Body Weight and Appetite Control , 2015, Front. Endocrinol..

[96]  H. Vaudry,et al.  The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis , 2015, PloS one.

[97]  J. Kwak,et al.  Overexpression of PGC‑1α enhances cell proliferation and tumorigenesis of HEK293 cells through the upregulation of Sp1 and Acyl-CoA binding protein. , 2015, International journal of oncology.

[98]  D. Stocco,et al.  PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO). , 2015, Endocrinology.

[99]  Wayne A Hendrickson,et al.  Structure and activity of tryptophan-rich TSPO proteins , 2015, Science.

[100]  R. Garavito,et al.  Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism , 2015, Science.

[101]  Dan J Stein.  Etifoxine Versus Alprazolam for the Treatment of Adjustment Disorder with Anxiety: a Randomized Controlled Trial , 2015, Advances in Therapy.

[102]  J. Jankiewicz-Wika,et al.  Reduced plasma level of diazepam-binding inhibitor (DBI) in patients with morbid obesity , 2015, Endocrine.

[103]  Jérôme Leprince,et al.  International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function , 2015, Pharmacological Reviews.

[104]  David Zahra,et al.  Positron emission tomography and functional characterization of a complete PBR/TSPO knockout , 2014, Nature Communications.

[105]  V. Papadopoulos,et al.  Structure-to-function relationships of bacterial translocator protein (TSPO): a focus on Pseudomonas , 2014, Front. Microbiol..

[106]  J. Tuech,et al.  Increased plasma levels of endozepines, endogenous ligands of benzodiazepine receptors, during systemic inflammation: a prospective observational study , 2014, Critical Care.

[107]  A. Graham,et al.  Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype. , 2014, Clinical science.

[108]  C. Steinhäuser,et al.  Heterogeneity in expression of functional ionotropic glutamate and GABA receptors in astrocytes across brain regions: insights from the thalamus , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[109]  P. Forcelli,et al.  Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats. , 2014, European journal of pharmacology.

[110]  Milos Pekny,et al.  Glia in the pathogenesis of neurodegenerative diseases. , 2014, Biochemical Society transactions.

[111]  V. Papadopoulos,et al.  Induction of androgen formation in the male by a TAT-VDAC1 fusion peptide blocking 14-3-3ɛ protein adaptor and mitochondrial VDAC1 interactions. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[112]  M. Pekny,et al.  Astrocyte reactivity and reactive astrogliosis: costs and benefits. , 2014, Physiological reviews.

[113]  R. Finn,et al.  Strain-dependent brain defects in mouse models of primary ciliary dyskinesia with mutations in Pcdp1 and Spef2 , 2014, Neuroscience.

[114]  T. Maniatis,et al.  An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex , 2014, The Journal of Neuroscience.

[115]  I. Módy,et al.  Interneuronal GABAA receptors inside and outside of synapses , 2014, Current Opinion in Neurobiology.

[116]  Jin Kwon Jeong,et al.  Leptin signaling in astrocytes regulates hypothalamic neuronal circuits and feeding , 2014, Nature Neuroscience.

[117]  Pierre P Massion,et al.  Acyl-Coenzyme A–Binding Protein Regulates Beta-Oxidation Required for Growth and Survival of Non–Small Cell Lung Cancer , 2014, Cancer Prevention Research.

[118]  L. Alberghina,et al.  Astrogliosis as a therapeutic target for neurodegenerative diseases , 2014, Neuroscience Letters.

[119]  Milos Pekny,et al.  The dual role of astrocyte activation and reactive gliosis , 2014, Neuroscience Letters.

[120]  S. Mandrup,et al.  Acyl-CoA binding protein and epidermal barrier function. , 2014, Biochimica et biophysica acta.

[121]  N. Paik,et al.  Functional Recovery After Ischemic Stroke Is Associated With Reduced GABAergic Inhibition in the Cerebral Cortex , 2014, Neurorehabilitation and neural repair.

[122]  U. Rudolph,et al.  GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. , 2014, Annual review of pharmacology and toxicology.

[123]  S. Mandrup,et al.  Delayed hepatic adaptation to weaning in ACBP-/- mice is caused by disruption of the epidermal barrier. , 2013, Cell reports.

[124]  J. Huguenard,et al.  Astrocytes potentiate GABAergic transmission in the thalamic reticular nucleus via endozepine signaling , 2013, Proceedings of the National Academy of Sciences.

[125]  P. Matthews,et al.  Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO)☆ , 2013, Psychoneuroendocrinology.

[126]  T. Hisatsune,et al.  Diazepam treatment blocks the elevation of hippocampal activity and the accelerated proliferation of hippocampal neural stem cells after focal cerebral ischemia in mice , 2013, Journal of neuroscience research.

[127]  S. Bouret,et al.  Tanycyte‐like cells form a blood–cerebrospinal fluid barrier in the circumventricular organs of the mouse brain , 2013, The Journal of comparative neurology.

[128]  H. Vaudry,et al.  Hypothalamic Glucose-sensing: Role of Glia-to-Neuron Signaling , 2013, Hormone and Metabolic Research.

[129]  L. Tremolizzo,et al.  Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. , 2013, The International journal of eating disorders.

[130]  S. Bauer,et al.  Cerebral Cell Renewal in Adult Mice Controls the Onset of Obesity , 2013, PloS one.

[131]  C. Zorumski,et al.  Neurosteroids as therapeutic leads in psychiatry. , 2013, JAMA psychiatry.

[132]  M. Kassiou,et al.  The translocator protein (TSPO): a novel target for cancer chemotherapy. , 2013, The international journal of biochemistry & cell biology.

[133]  G. Guerrini,et al.  Benzodiazepine receptor ligands: a patent review (2006 – 2012) , 2013, Expert opinion on therapeutic patents.

[134]  J. Huguenard,et al.  Endogenous Positive Allosteric Modulation of GABAA Receptors by Diazepam binding inhibitor , 2013, Neuron.

[135]  N. Seidah,et al.  The Multifaceted Proprotein Convertases: Their Unique, Redundant, Complementary, and Opposite Functions* , 2013, The Journal of Biological Chemistry.

[136]  Alan D Kaye,et al.  Benzodiazepine pharmacology and central nervous system-mediated effects. , 2013, The Ochsner journal.

[137]  Hagen B. Huttner,et al.  Dynamics of Hippocampal Neurogenesis in Adult Humans , 2013, Cell.

[138]  V. Papadopoulos,et al.  Organelle plasticity and interactions in cholesterol transport and steroid biosynthesis , 2013, Molecular and Cellular Endocrinology.

[139]  Jay Shendure,et al.  The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line , 2013, Nature.

[140]  H. Vaudry,et al.  The octadecaneuropeptide ODN prevents 6‐hydroxydopamine‐induced apoptosis of cerebellar granule neurons through a PKC‐MAPK‐dependent pathway , 2013, Journal of neurochemistry.

[141]  M. Gavish,et al.  Role of mitochondrial translocator protein (18 kDa) on mitochondrial- related cell death processes. , 2013, Recent patents on endocrine, metabolic & immune drug discovery.

[142]  P. Carmeliet,et al.  Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. , 2013, Cell metabolism.

[143]  Joshua A. Kritzer,et al.  Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints. , 2013, ACS chemical biology.

[144]  H. Vaudry,et al.  The Octadecaneuropeptide Stimulates Somatolactin Release from Cultured Goldfish Pituitary Cells , 2013, Journal of neuroendocrinology.

[145]  H. Vaudry,et al.  Gliotransmission and Brain Glucose Sensing , 2013, Diabetes.

[146]  W. Lubell,et al.  Peptide Scanning for Studying Structure‐Activity Relationships in Drug Discovery , 2013, Chemical biology & drug design.

[147]  Richard A. Gibbs,et al.  Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic Population , 2012, PloS one.

[148]  Brendon O. Watson,et al.  Brain rhythms and neural syntax: implications for efficient coding of cognitive content and neuropsychiatric disease. , 2012, Dialogues in clinical neuroscience.

[149]  S. Mandrup,et al.  The acyl-CoA binding protein is required for normal epidermal barrier function in mice[S] , 2012, Journal of Lipid Research.

[150]  T. Veenstra,et al.  Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. , 2012, Molecular endocrinology.

[151]  Jérôme Leprince,et al.  The Octadecaneuropeptide ODN Protects Astrocytes against Hydrogen Peroxide-Induced Apoptosis via a PKA/MAPK-Dependent Mechanism , 2012, PloS one.

[152]  K. Braun,et al.  9‐Methyl‐β‐carboline‐induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation , 2012, Journal of neurochemistry.

[153]  S. Gandhi,et al.  Mechanism of Oxidative Stress in Neurodegeneration , 2012, Oxidative medicine and cellular longevity.

[154]  M. Gavish,et al.  The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. , 2012, Current molecular medicine.

[155]  T. Baram,et al.  Sculpting the hippocampus from within: stress, spines, and CRH , 2012, Trends in Neurosciences.

[156]  R. Thuillier,et al.  Role of translocator protein in renal ischemia reperfusion, renal preservation and acute kidney injury. , 2012, Current molecular medicine.

[157]  V. Papadopoulos,et al.  Structural and functional evolution of the translocator protein (18 kDa). , 2012, Current molecular medicine.

[158]  H. Vaudry,et al.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1 , 2012, British journal of pharmacology.

[159]  S. Mandrup,et al.  Mice with targeted disruption of the acyl-CoA binding protein display attenuated urine concentrating ability and diminished renal aquaporin-3 abundance. , 2012, American journal of physiology. Renal physiology.

[160]  G. Fishell,et al.  Tanycytes of the Hypothalamic Median Eminence Form a Diet-Responsive Neurogenic Niche , 2012, Nature Neuroscience.

[161]  G. Dockray.  Cholecystokinin , 2012, Current opinion in endocrinology, diabetes, and obesity.

[162]  H. Monyer,et al.  Diazepam binding inhibitor promotes progenitor proliferation in the postnatal SVZ by reducing GABA signaling. , 2012, Cell stem cell.

[163]  V. Papadopoulos,et al.  Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa , 2012, Journal of neuroendocrinology.

[164]  S. Opal,et al.  Proprotein convertases in health and disease. , 2011, The New England journal of medicine.

[165]  W. Miller,et al.  Early steps in steroidogenesis: intracellular cholesterol trafficking , 2011, Journal of Lipid Research.

[166]  H. Vaudry,et al.  The Brain of Teleost Fish, a Source, and a Target of Sexual Steroids , 2011, Front. Neurosci..

[167]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[168]  M. Beato,et al.  Chloride Ions in the Pore of Glycine and GABA Channels Shape the Time Course and Voltage Dependence of Agonist Currents , 2011, The Journal of Neuroscience.

[169]  F. Knoflach,et al.  Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes , 2011, Nature Reviews Drug Discovery.

[170]  H. Vaudry,et al.  Protective effect of the octadecaneuropeptide on hydrogen peroxide‐induced oxidative stress and cell death in cultured rat astrocytes , 2011, Journal of neurochemistry.

[171]  N. Færgeman,et al.  Tissue- and paralogue-specific functions of acyl-CoA-binding proteins in lipid metabolism in Caenorhabditis elegans. , 2011, The Biochemical journal.

[172]  H. Vaudry,et al.  The octadecaneuropeptide exerts an anxiogenic-like action in goldfish , 2011, Neuroscience.

[173]  Kelly R. Tan,et al.  Hooked on benzodiazepines: GABAA receptor subtypes and addiction , 2011, Trends in Neurosciences.

[174]  R. Rupprecht,et al.  Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain , 2011, Synapse.

[175]  A. Clark,et al.  The melanocortin receptors and their accessory proteins , 2011, Front. Endocrin..

[176]  V. Papadopoulos,et al.  Novel Androstenetriol Interacts with the Mitochondrial Translocator Protein and Controls Steroidogenesis* , 2011, The Journal of Biological Chemistry.

[177]  Gerhard Rammes,et al.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders , 2010, Nature Reviews Drug Discovery.

[178]  M. Kruhøffer,et al.  Disruption of the Acyl-CoA-binding Protein Gene Delays Hepatic Adaptation to Metabolic Changes at Weaning* , 2010, The Journal of Biological Chemistry.

[179]  I. Módy,et al.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. , 2010, Nature.

[180]  V. Papadopoulos,et al.  Regulation of translocator protein 18kDa (TSPO) expression in health and disease states , 2010, Molecular and Cellular Endocrinology.

[181]  Jun Liu,et al.  Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. , 2010, Progress in lipid research.

[182]  C. Tirolo,et al.  Glia as a turning point in the therapeutic strategy of Parkinson's disease. , 2010, CNS & neurological disorders drug targets.

[183]  W. Sieghart,et al.  The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. , 2010, European journal of pharmacology.

[184]  A. McIntosh,et al.  Acyl-CoA Binding Protein Gene Ablation Induces Pre-implantation Embryonic Lethality in Mice , 2010, Lipids.

[185]  C. Sachse,et al.  Three-Dimensional Structure of TspO by Electron Cryomicroscopy of Helical Crystals , 2010, Structure.

[186]  C. Anjard,et al.  Pregnenolone Sulfate and Cortisol Induce Secretion of Acyl-CoA-binding Protein and Its Conversion into Endozepines from Astrocytes* , 2010, The Journal of Biological Chemistry.

[187]  S. Mennerick,et al.  Structurally diverse amphiphiles exhibit biphasic modulation of GABAA receptors: similarities and differences with neurosteroid actions , 2010, British journal of pharmacology.

[188]  J. Trotter,et al.  NG2 cells: Properties, progeny and origin , 2010, Brain Research Reviews.

[189]  H. Vaudry,et al.  Acute food deprivation reduces expression of diazepam-binding inhibitor, the precursor of the anorexigenic octadecaneuropeptide ODN, in mouse glial cells. , 2010, Journal of molecular endocrinology.

[190]  Hélène Castel,et al.  The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation. , 2010, The Biochemical journal.

[191]  S. Bouret,et al.  Differential distribution of tight junction proteins suggests a role for tanycytes in blood‐hypothalamus barrier regulation in the adult mouse brain , 2010, The Journal of comparative neurology.

[192]  H. Vaudry,et al.  The Anorexigenic Action of the Octadecaneuropeptide (ODN) in Goldfish is Mediated Through the MC4R- and Subsequently the CRH Receptor-Signaling Pathways , 2010, Journal of Molecular Neuroscience.

[193]  F. Döring,et al.  Specific regulation of low-abundance transcript variants encoding human Acyl-CoA binding protein (ACBP) isoforms , 2010, Journal of cellular and molecular medicine.

[194]  C. Anjard,et al.  Unconventional secretion of Acb1 is mediated by autophagosomes , 2010, The Journal of cell biology.

[195]  J. Spiess,et al.  Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system , 2009, Molecular Psychiatry.

[196]  Z. Du,et al.  An acyl-CoA-binding protein (FcACBP) and a fatty acid binding protein (FcFABP) respond to microbial infection in Chinese white shrimp, Fenneropenaeus chinensis. , 2009, Fish & shellfish immunology.

[197]  Hans-Ulrich Demuth,et al.  Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain , 2009, International Journal of Developmental Neuroscience.

[198]  G. Cavaletti,et al.  Neuroprotective effects of a ligand of translocator protein-18kDa (Ro5-4864) in experimental diabetic neuropathy , 2009, Neuroscience.

[199]  C. Moskaluk,et al.  Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy. , 2009, The American journal of pathology.

[200]  A. Colell,et al.  Mitochondrial glutathione, a key survival antioxidant. , 2009, Antioxidants & redox signaling.

[201]  V. Papadopoulos,et al.  Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine , 2009, Biology of the cell.

[202]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery , 2009, Pharmacological Reviews.

[203]  R. Weselake,et al.  A 10-kDa acyl-CoA-binding protein (ACBP) from Brassica napus enhances acyl exchange between acyl-CoA and phosphatidylcholine. , 2009, Plant biotechnology journal.

[204]  V. Papadopoulos,et al.  Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma , 2009, Experimental Neurology.

[205]  F. Da Settimo,et al.  Translocator protein ligands as promising therapeutic tools for anxiety disorders. , 2009, Current medicinal chemistry.

[206]  J. Spiess,et al.  Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning , 2009, Neuroscience.

[207]  J. Conlon,et al.  Antimicrobial peptides from the skins of North American frogs. , 2009, Biochimica et biophysica acta.

[208]  H. Vaudry,et al.  Neurosteroid biosynthesis: Enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides , 2009, Frontiers in Neuroendocrinology.

[209]  Michael Kassiou,et al.  Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. , 2009, Current medicinal chemistry.

[210]  F. Holsboer,et al.  Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects , 2009, Science.

[211]  J. Ott,et al.  Heroin addiction in African Americans: a hypothesis‐driven association study , 2009, Genes, brain, and behavior.

[212]  V. Papadopoulos,et al.  Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. , 2009, Biochimica et biophysica acta.

[213]  A. Jean,et al.  Prostaglandins and sickness behavior: Old story, new insights , 2009, Physiology & Behavior.

[214]  Stephan Kutik,et al.  Evolution of mitochondrial protein biogenesis. , 2009, Biochimica et biophysica acta.

[215]  V. Papadopoulos,et al.  Expression and modulation of translocator protein and its partners by hypoxia reoxygenation or ischemia and reperfusion in porcine renal models. , 2009, American journal of physiology. Renal physiology.

[216]  S. Galderisi,et al.  Ala147Thr substitution in translocator protein is associated with adult separation anxiety in patients with depression. , 2009, Psychiatric genetics.

[217]  Tuula Tolvanen,et al.  Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[218]  Catherine Rabouille,et al.  Mechanisms of regulated unconventional protein secretion , 2009, Nature Reviews Molecular Cell Biology.

[219]  R. Olsen,et al.  GABAA receptors: Subtypes provide diversity of function and pharmacology , 2009, Neuropharmacology.

[220]  H. Vaudry,et al.  Beta‐amyloid peptide stimulates endozepine release in cultured rat astrocytes through activation of N‐formyl peptide receptors , 2008, Glia.

[221]  Joshua P. Smith,et al.  Anxiety and Substance Use Disorders: A Review. , 2008, The Psychiatric times.

[222]  L. Alhonen,et al.  Effect of medium‐ and long‐chain fatty acid diets on PPAR and SREBP‐1 expression and glucose homeostasis in ACBP‐overexpressing transgenic rats , 2008, Acta physiologica.

[223]  Werner Sieghart,et al.  International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update , 2008, Pharmacological Reviews.

[224]  C. Wasternack,et al.  Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution , 2008, Biological chemistry.

[225]  D. Reynolds.  The value of genetic and pharmacological approaches to understanding the complexities of GABAA receptor subtype functions: The anxiolytic effects of benzodiazepines , 2008, Pharmacology Biochemistry and Behavior.

[226]  T. Solstad,et al.  Identification of a novel phosphorylation site of acyl-CoA binding protein (ACBP) in nodularin-induced apoptotic hepatocytes. , 2008, Experimental cell research.

[227]  V. Papadopoulos,et al.  Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding. , 2008, Biochimica et biophysica acta.

[228]  N. Barmack,et al.  Acyl coenzyme A‐binding protein (ACBP) is phosphorylated and secreted by retinal Müller astrocytes following protein kinase C activation , 2008, Journal of neurochemistry.

[229]  H. Vaudry,et al.  Effect of GABAA receptor activation on UT-coupled signaling pathways in rat cortical astrocytes , 2008, Peptides.

[230]  L. Alhonen,et al.  Downregulation of PPARs and SREBP by acyl-CoA-binding protein overexpression in transgenic rats , 2008, Pflügers Archiv - European Journal of Physiology.

[231]  Daniel W Byrne,et al.  Acute administration of methamphetamine decreases the mRNA expression of diazepam binding inhibitor in rat brain. , 2008, The Tokai Journal of Experimental and Clinical Medicine.

[232]  James Robert Brašić,et al.  VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease , 2008, Journal of neurochemistry.

[233]  Ming-Kai Chen,et al.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.

[234]  A. Giuditta,et al.  Local gene expression in axons and nerve endings: the glia-neuron unit. , 2008, Physiological reviews.

[235]  B. Kragelund,et al.  Acyl-CoA-binding protein (ACBP) localizes to the endoplasmic reticulum and Golgi in a ligand-dependent manner in mammalian cells. , 2008, The Biochemical journal.

[236]  H. McFarlane,et al.  Autism‐like behavioral phenotypes in BTBR T+tf/J mice , 2008, Genes, brain, and behavior.

[237]  G. Buzsáki,et al.  Inhibition and Brain Work , 2007, Neuron.

[238]  H. Vaudry,et al.  Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish , 2007, Neuroscience.

[239]  H. Raybould,et al.  Mechanisms of CCK signaling from gut to brain. , 2007, Current opinion in pharmacology.

[240]  H. Bohr,et al.  Detection of initiation sites in protein folding of the four helix bundle ACBP by chemical shift analysis , 2007, FEBS letters.

[241]  J. Crawley.  Mouse Behavioral Assays Relevant to the Symptoms of Autism * , 2007, Brain pathology.

[242]  F. Holsboer,et al.  Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. , 2007, Journal of psychiatric research.

[243]  M. Shibasaki,et al.  Increase in diazepam binding inhibitor expression by sustained morphine exposure is mediated via μ‐opioid receptors in primary cultures of mouse cerebral cortical neurons , 2007, Journal of neuroscience research.

[244]  V. Papadopoulos,et al.  Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. , 2007, Current pharmaceutical design.

[245]  K. Ikeda,et al.  The relationship between alcoholism and DBI gene polymorphism in Japanese--genotyping of the +529A/T in DBI gene polymorphism based on PCR. , 2007, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.

[246]  H. Vaudry,et al.  Pharmacological Characterization of the Receptor Mediating the Anorexigenic Action of the Octadecaneuropeptide: Evidence for an Endozepinergic Tone Regulating Food Intake , 2007, Neuropsychopharmacology.

[247]  V. Papadopoulos,et al.  The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. , 2007, Cell calcium.

[248]  Elizabeth L. Ogburn,et al.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2007, Archives of general psychiatry.

[249]  H. Vaudry,et al.  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants. , 2007, Journal of medicinal chemistry.

[250]  Elizabeth Gould,et al.  How widespread is adult neurogenesis in mammals? , 2007, Nature Reviews Neuroscience.

[251]  S. Weng,et al.  Profiling of differentially expressed genes in hepatopancreas of white spot syndrome virus-resistant shrimp (Litopenaeus vannamei) by suppression subtractive hybridisation. , 2007, Fish & shellfish immunology.

[252]  B. Kragelund,et al.  Acyl-CoA binding proteins; structural and functional conservation over 2000 MYA , 2007, Molecular and Cellular Biochemistry.

[253]  Shigeyoshi Itohara,et al.  GABAergic Control of Adult Hippocampal Neurogenesis in Relation to Behavior Indicative of Trait Anxiety and Depression States , 2007, The Journal of Neuroscience.

[254]  M. Penttonen,et al.  Diazepam binding inhibitor overexpression in mice causes hydrocephalus, decreases plasticity in excitatory synapses and impairs hippocampus-dependent learning , 2007, Molecular and Cellular Neuroscience.

[255]  Jun Liu,et al.  Is there a mitochondrial signaling complex facilitating cholesterol import? , 2007, Molecular and Cellular Endocrinology.

[256]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[257]  H. Vaudry,et al.  Immunohistochemical localization and biological activity of the steroidogenic enzyme cytochrome P450 17α‐hydroxylase/C17, 20‐lyase (P450C17) in the frog brain and pituitary , 2007, Journal of neurochemistry.

[258]  B. Christie,et al.  Exercise-induced changes in dendritic structure and complexity in the adult hippocampal dentate gyrus , 2006, Neuroscience.

[259]  M. Shibasaki,et al.  Up-regulated L-type high voltage-gated calcium channels cause increase in diazepam binding inhibitor induced by sustained morphine exposure in mouse cerebrocortical neurons. , 2006, Life sciences.

[260]  H. Vaudry,et al.  Role of androgens and glucocorticoids in the regulation of diazepam-binding inhibitor mRNA levels in male mouse hypothalamus , 2006, Brain Research.

[261]  G. Dawson,et al.  L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors , 2006, Neuropharmacology.

[262]  J. G. Pastorino,et al.  Acyl Coenzyme A-binding Protein Augments Bid-induced Mitochondrial Damage and Cell Death by Activating μ-Calpain* , 2006, Journal of Biological Chemistry.

[263]  H. Vaudry,et al.  Biochemical and functional characterization of high‐affinity urotensin II receptors in rat cortical astrocytes , 2006, Journal of neurochemistry.

[264]  Erminio Costa,et al.  Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis , 2006, Proceedings of the National Academy of Sciences.

[265]  K. Ukena,et al.  Neurosteroid biosynthesis in the quail brain: a review. , 2006, Journal of experimental zoology. Part A, Comparative experimental biology.

[266]  D. Nutt,et al.  Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.

[267]  J. Soustiel,et al.  Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival , 2006, Journal of Neuro-Oncology.

[268]  H. Vaudry,et al.  PACAP Stimulates Biosynthesis and Release of Endozepines from Rat Astrocytes , 2006, Annals of the New York Academy of Sciences.

[269]  H. Vaudry,et al.  Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: Identification of an unusual cleavage site , 2006, Peptides.

[270]  M. Gavish,et al.  The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. , 2006, Pharmacology & therapeutics.

[271]  K. Ikeda,et al.  Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[272]  Abraham Weizman,et al.  The relevance of neurosteroids to clinical psychiatry: From the laboratory to the bedside , 2006, European Neuropsychopharmacology.

[273]  L. Gentet,et al.  Neuroactive steroids and inhibitory neurotransmission: Mechanisms of action and physiological relevance , 2006, Neuroscience.

[274]  Y. Nishida,et al.  Regulation of hypothalamic gene expression by glucocorticoid: implications for energy homeostasis. , 2006, Physiological genomics.

[275]  N Collinson,et al.  An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition , 2006, Journal of Pharmacology and Experimental Therapeutics.

[276]  U. Rudolph,et al.  GABA-based therapeutic approaches: GABAA receptor subtype functions. , 2006, Current opinion in pharmacology.

[277]  H. Vaudry,et al.  New synthesis of cis 5‐tert‐butyl‐L‐proline via cuprate. Evaluation as a cis proline mimetic in a biological active octapeptide , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[278]  W. Sieghart,et al.  Pharmacological Properties of GABAA Receptors Containing γ1 Subunits , 2006, Molecular Pharmacology.

[279]  P. Kiilerich,et al.  ACBP – a PPAR and SREBP modulated housekeeping gene , 2006, Molecular and Cellular Biochemistry.

[280]  C. Vock,et al.  ACBP Knockdown Leads to Down-regulation of Genes Encoding Rate-limiting Enzymes in Cholesterol and Fatty Acid Metabolism , 2006, Cellular Physiology and Biochemistry.

[281]  K. Ishimura,et al.  Localization of 5α‐reductase in the rat main olfactory bulb , 2005 .

[282]  M. Schumacher,et al.  The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain , 2005, Pharmacology Biochemistry and Behavior.

[283]  Timothy M Rose,et al.  Evolution of the acyl-CoA binding protein (ACBP). , 2005, The Biochemical journal.

[284]  H. Vaudry,et al.  In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat. , 2005, Brain research. Molecular brain research.

[285]  J. J. Sharp,et al.  nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. , 2005, Blood.

[286]  M. Abdelrahim,et al.  Sp transcription factor family and its role in cancer. , 2005, European journal of cancer.

[287]  J. Schrezenmeir,et al.  Identification of new acyl-CoA binding protein transcripts in human and mouse. , 2005, The international journal of biochemistry & cell biology.

[288]  J. Flier,et al.  Neurogenesis in the Hypothalamus of Adult Mice: Potential Role in Energy Balance , 2005, Science.

[289]  A. H. Wang,et al.  Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[290]  H. Vaudry,et al.  Somatostatin down‐regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes , 2005, Journal of neurochemistry.

[291]  H. Vaudry,et al.  Beta‐amyloid peptides stimulate endozepine biosynthesis in cultured rat astrocytes , 2005, Journal of neurochemistry.

[292]  B. Atshaves,et al.  Acyl-coenzyme A binding protein expression alters liver fatty acyl-coenzyme A metabolism. , 2005, Biochemistry.

[293]  J. Lambert,et al.  Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.

[294]  Hong-xian Chen,et al.  Conditioned place preference associates with the mRNA expression of diazepam binding inhibitor in brain regions of the addicted rat during withdrawal. , 2005, Brain research. Molecular brain research.

[295]  P. Somogyi,et al.  Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor γ2 F77I point mutation , 2005, The European journal of neuroscience.

[296]  E. Sigel,et al.  Benzodiazepines Affect Channel Opening of GABAA Receptors Induced by Either Agonist Binding Site , 2005, Molecular Pharmacology.

[297]  Yusuke Nakamura,et al.  Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers through Genome-Wide Gene Expression Profiling , 2005, Clinical Cancer Research.

[298]  K. Teilum,et al.  Different secondary structure elements as scaffolds for protein folding transition states of two homologous four‐helix bundles , 2005, Proteins.

[299]  V. Papadopoulos,et al.  Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. , 2005, Molecular endocrinology.

[300]  W. Wisden,et al.  Agonistic effects of the β-carboline DMCM revealed in GABAA receptor γ2 subunit F77I point-mutated mice , 2005, Neuropharmacology.

[301]  S. Mandrup,et al.  The Gene Encoding Acyl-CoA-binding Protein Is Subject to Metabolic Regulation by Both Sterol Regulatory Element-binding Protein and Peroxisome Proliferator-activated Receptor α in Hepatocytes* , 2005, Journal of Biological Chemistry.

[302]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria , 2005 .

[303]  H. Vaudry,et al.  In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain , 2004, Neuroscience.

[304]  E. Baulieu,et al.  7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[305]  D. B. Hales,et al.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. , 2004, Endocrine reviews.

[306]  William Wisden,et al.  Affinity of various benzodiazepine site ligands in mice with a point mutation in the GABA(A) receptor gamma2 subunit. , 2004, Biochemical pharmacology.

[307]  Hassan Oulyadi,et al.  Structure–activity relationships and structural conformation of a novel urotensin II-related peptide , 2004, Peptides.

[308]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[309]  R. Schneiter,et al.  Acyl-CoA-binding protein, Acb1p, is required for normal vacuole function and ceramide synthesis in Saccharomyces cerevisiae. , 2004, The Biochemical journal.

[310]  S. L. la Fleur,et al.  Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004. , 2004, Endocrinology.

[311]  M. Tachi,et al.  Continuous exposure to nitric oxide enhances diazepam binding inhibitor mRNA expression in mouse cerebral cortical neurons. , 2004, Brain research. Molecular brain research.

[312]  M. Patil,et al.  Behavioral / Systems / Cognitive Corticotrophin Releasing Factor-Induced Synaptic Plasticity in the Amygdala Translates Stress into Emotional Disorders , 2004 .

[313]  Kiweon Cha,et al.  Microarray analysis of differentially expressed genes associated with human ovarian cancer. , 2004, International journal of oncology.

[314]  Andrew Kramar,et al.  Immunohistochemical Assessment of the Peripheral Benzodiazepine Receptor in Breast Cancer and Its Relationship with Survival , 2004, Clinical Cancer Research.

[315]  L. Heston,et al.  Multiple missense mutations in the diazepam binding inhibitor (DBI) gene identified in schizophrenia but lack of disease association , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[316]  N. Barmack,et al.  Activity-Dependent Expression of Acyl-Coenzyme A-Binding Protein in Retinal Muller Glial Cells Evoked by Optokinetic Stimulation , 2004, The Journal of Neuroscience.

[317]  Toshio Matsuda,et al.  Astrocyte apoptosis: implications for neuroprotection , 2004, Progress in Neurobiology.

[318]  S. Galiègue,et al.  Immunohistochemical Assessment of the Peripheral Benzodiazepine Receptor in Human Tissues , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[319]  H. Vaudry,et al.  Characterization of endozepines in the human testicular tissue: effect of triakontatetraneuropeptide on testosterone secretion. , 2003, The Journal of clinical endocrinology and metabolism.

[320]  Andrew G. Leach,et al.  Binding affinities of host-guest, protein-ligand, and protein-transition-state complexes. , 2003, Angewandte Chemie.

[321]  G. Dawson,et al.  Sedation and Anesthesia Mediated by Distinct GABAA Receptor Isoforms , 2003, The Journal of Neuroscience.

[322]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. , 2003, Steroids.

[323]  P. Marin,et al.  Proteomic Analysis of Astrocytic Secretion in the Mouse , 2003, Journal of Biological Chemistry.

[324]  M. Katsura,et al.  L-type high voltage-gated calcium channels cause an increase in diazepam binding inhibitor mRNA expression after sustained exposure to ethanol in mouse cerebral cortical neurons. , 2003, Brain research. Molecular brain research.

[325]  A. Fietta,et al.  Interleukin-8 production induced by the endozepine triakontatetraneuropeptide in human neutrophils: role of calcium and pharmacological investigation of signal transduction pathways. , 2003, Cellular signalling.

[326]  Pierre Renard,et al.  Structure–Activity Relationships of Human Urotensin II and Related Analogues on Rat Aortic Ring Contraction , 2003, Journal of enzyme inhibition and medicinal chemistry.

[327]  F. Schliess,et al.  Benzodiazepine‐induced protein tyrosine nitration in rat astrocytes , 2003, Hepatology.

[328]  H. Vaudry,et al.  Effect of Intracerebroventricular Administration of the Octadecaneuropeptide on the Expression of Pro‐Opiomelanocortin, Neuropeptide Y and Corticotropin‐Releasing Hormone mRNAs in Rat Hypothalamus , 2003, Journal of neuroendocrinology.

[329]  V. Papadopoulos,et al.  Expression of Peripheral Benzodiazepine Receptor (PBR) in Human Tumors: Relationship to Breast, Colorectal, and Prostate Tumor Progression , 2003, Journal of receptor and signal transduction research.

[330]  H. Vaudry,et al.  Pituitary adenylate cyclase‐activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA‐dependent mechanism , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[331]  J. Knudsen,et al.  Acyl-CoA binding protein is an essential protein in mammalian cell lines. , 2002, The Biochemical journal.

[332]  M. Gazouli,et al.  Identification of a Peptide Antagonist to the Peripheral-Type Benzodiazepine Receptor That Inhibits Hormone-Stimulated Leydig Cell Steroid Formation , 2002, Journal of Pharmacology and Experimental Therapeutics.

[333]  C. Jefcoate.  High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex. , 2002, The Journal of clinical investigation.

[334]  K. Ukena,et al.  Androgen biosynthesis in the quail brain , 2002, Brain Research.

[335]  U. Rudolph,et al.  Contribution of the α1-GABAA receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists , 2002, Neuropharmacology.

[336]  G. Homanics,et al.  GABAA receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem , 2002, Neuropharmacology.

[337]  G. Sperk,et al.  Subunit composition, distribution and function of GABA(A) receptor subtypes. , 2002, Current topics in medicinal chemistry.

[338]  K. Kristiansen,et al.  The Gene Encoding the Acyl-CoA-binding Protein Is Activated by Peroxisome Proliferator-activated Receptor γ through an Intronic Response Element Functionally Conserved between Humans and Rodents* , 2002, The Journal of Biological Chemistry.

[339]  M. Ukai,et al.  Psychological stress, but not physical stress, causes increase in diazepam binding inhibitor (DBI) mRNA expression in mouse brains. , 2002, Brain research. Molecular brain research.

[340]  F. Kuenzi,et al.  Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor , 2002, The Journal of Neuroscience.

[341]  M. Raiteri,et al.  International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function , 2002, Pharmacological Reviews.

[342]  Philip E. Johnson,et al.  Export of acyl chains from plastids isolated from embryos of Brassica napus (L.) , 2002, Planta.

[343]  S. Galiègue,et al.  Peripheral benzodiazepine receptors and mitochondrial function , 2002, Neurochemistry International.

[344]  T. Iwanaga,et al.  Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with brain-type fatty acid binding protein. , 2002, Archives of histology and cytology.

[345]  F. Schroeder,et al.  Acyl‐CoA Binding Protein , 2002 .

[346]  H. Vaudry,et al.  Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. , 2001, European journal of biochemistry.

[347]  Y. Manabe,et al.  Effect of diazepam binding inhibitor (DBI) on the fluid intake, preference and the taste reactivity in mice , 2001, Behavioural Brain Research.

[348]  C. Zorumski,et al.  Recent developments in structure–activity relationships for steroid modulators of GABAA receptors , 2001, Brain Research Reviews.

[349]  T. Iwanaga,et al.  Cellular localization of the diazepam binding inhibitor (DBI) in the gastrointestinal tract of mice and its coexistence with the fatty acid binding protein (FABP). , 2001, Archives of histology and cytology.

[350]  H. Vaudry,et al.  The triakontatetraneuropeptide TTN increases [Ca2+]i in rat astrocytes through activation of peripheral‐type benzodiazepine receptors , 2001, Glia.

[351]  V. Papadopoulos,et al.  Structural and functional study of reconstituted peripheral benzodiazepine receptor. , 2001, Biochemical and biophysical research communications.

[352]  M. Moghadasian,et al.  Overexpression of acyl-CoA binding protein and its effects on the flux of free fatty acids in McA-RH 7777 cells , 2001, Lipids.

[353]  G J Kleywegt,et al.  Binding site differences revealed by crystal structures of Plasmodium falciparum and bovine acyl-CoA binding protein. , 2001, Journal of molecular biology.

[354]  J. Andersen,et al.  Depletion of acyl-coenzyme A-binding protein affects sphingolipid synthesis and causes vesicle accumulation and membrane defects in Saccharomyces cerevisiae. , 2001, Molecular biology of the cell.

[355]  A. Jean.  Brain stem control of swallowing: neuronal network and cellular mechanisms. , 2001, Physiological reviews.

[356]  S. Goldberg,et al.  Differences in genetic predisposition to high anxiety in two inbred rat strains: role of substance P, diazepam binding inhibitor fragment and neuropeptide Y , 2001, Psychopharmacology.

[357]  M. Katsura,et al.  NMDA receptor activation enhances diazepam binding inhibitor and its mRNA expressions in mouse cerebral cortical neurons. , 2001, Brain research. Molecular brain research.

[358]  H. Vaudry,et al.  The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. , 2001, European journal of pharmacology.

[359]  M. Ferguson,et al.  Acyl-CoA binding protein is essential in bloodstream form Trypanosoma brucei. , 2001, Molecular and biochemical parasitology.

[360]  M. Katsura,et al.  Alterations in cerebral diazepam binding inhibitor expression in drug dependence: a possible biochemical alteration common to drug dependence. , 2001, Life sciences.

[361]  V. Papadopoulos,et al.  Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[362]  H. Vaudry,et al.  The octadecaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central‐type benzodiazepine receptors , 2001, Journal of neurochemistry.

[363]  Y. Manabe,et al.  Diazepam-binding inhibitor-like activity in rat cerebrospinal fluid after stimulation by an aversive quinine taste. , 2000, Chemical senses.

[364]  Hans-Dieter Höltje,et al.  Development of a unique 3D interaction model of endogenous and synthetic peripheral benzodiazepine receptor ligands , 2000, J. Comput. Aided Mol. Des..

[365]  T. Rülicke,et al.  Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.

[366]  M. Gavish,et al.  Tissue-Specific Regulation of the Peripheral Benzodiazepine Receptor by Antidepressants and Lithium , 2000, Neuropsychobiology.

[367]  H. Vaudry,et al.  The Triakontatetraneuropeptide (TTN) Stimulates Thymidine Incorporation in Rat Astrocytes Through Peripheral‐Type Benzodiazepine Receptors , 2000, Journal of neurochemistry.

[368]  A. Augello,et al.  Immunoreactive Endozepine-like Peptides in the Brain and Pituitary of the Atlantic Hagfish, Myxine Glutinosa , 2000, The Histochemical Journal.

[369]  A. Fietta,et al.  Diazepam‐binding inhibitor‐derived peptides induce intracellular calcium changes and modulate human neutrophil function , 2000, Journal of leukocyte biology.

[370]  G. Johnston,et al.  GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology. , 2000, Journal of medicinal chemistry.

[371]  T. Guilarte,et al.  Cellular and Subcellular Localization of Peripheral Benzodiazepine Receptors After Trimethyltin Neurotoxicity , 2000, Journal of neurochemistry.

[372]  C. Steinhäuser,et al.  Ion channels in glial cells , 2000, Brain Research Reviews.

[373]  K. Kristiansen,et al.  Long-chain acyl-CoA esters and acyl-CoA binding protein are present in the nucleus of rat liver cells. , 2000, Journal of lipid research.

[374]  P. Riederer,et al.  Identification of benzodiazepines in Artemisia dracunculus and Solanum tuberosum rationalizing their endogenous formation in plant tissue. , 2000, Biochemical and biophysical research communications.

[375]  Y. Hao,et al.  Diazepam-binding inhibitor mediates feedback regulation of pancreatic secretion and postprandial release of cholecystokinin. , 2000, The Journal of clinical investigation.

[376]  R. F. Parrott,et al.  Behavioral and Hormonal Effects of Centrally Injected “Anxiogenic” Neuropeptides in Growing Pigs , 2000, Pharmacology Biochemistry and Behavior.

[377]  Abraham Weizman,et al.  Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.

[378]  H. Vaudry,et al.  Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN☆ , 1999, Peptides.

[379]  T J Sejnowski,et al.  Running enhances neurogenesis, learning, and long-term potentiation in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[380]  J. Benson,et al.  Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes , 1999, Nature.

[381]  M. Baraldi,et al.  Increased expression of peripheral benzodiazepine receptors and diazepam binding inhibitor in human tumors sited in the liver. , 1999, Life sciences.

[382]  K. Ukena,et al.  Neurosteroid biosynthesis in vertebrate brains. , 1999, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.

[383]  Bernhard Lüscher,et al.  Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues , 1999, Nature Neuroscience.

[384]  Karsten Kristiansen,et al.  The formation of a native-like structure containing eight conserved hydrophobic residues is rate limiting in two-state protein folding of ACBP , 1999, Nature Structural Biology.

[385]  H. Vaudry,et al.  The endozepine ODN stimulates [3H]thymidine incorporation in cultured rat astrocytes , 1999, Neuropharmacology.

[386]  G. Pelletier,et al.  Differential involvement of adrenal and gonadal steroids in anterior and intermediate pituitary pro-opiomelanocortin mRNA expression induced by the endogenous benzodiazepine, octadecaneuropeptide, in adult male rats. , 1999, The Journal of endocrinology.

[387]  V. Papadopoulos,et al.  In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[388]  C. Owyang,et al.  Diazepam-binding inhibitor33-50 elicits Ca2+ oscillation and CCK secretion in STC-1 cells via L-type Ca2+ channels. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[389]  H. Vaudry,et al.  Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. , 1999, Pharmacological reviews.

[390]  H. Vaudry,et al.  GABA inhibits endozepine release from cultured rat astrocytes , 1999, Glia.

[391]  K. Kristiansen,et al.  Conserved residues and their role in the structure, function, and stability of acyl-coenzyme A binding protein. , 1999, Biochemistry.

[392]  H. Vaudry,et al.  Immunocytochemical Localization and Biological Activity of Hydroxysteroid Sulfotransferase in the Frog Brain , 1999, Journal of neurochemistry.

[393]  Lauber,et al.  Ontogeny of Diazepam Binding Inhibitor/Acyl‐CoA Binding Protein mRNA and Peripheral Benzodiazepine Receptor mRNA Expression in the Rat1 , 1999, Journal of neuroendocrinology.

[394]  M. Feuilloley,et al.  The endozepine triakontatetraneuropeptide diazepam-binding inhibitor [17–50] stimulates neurosteroid biosynthesis in the frog hypothalamus , 1998, Neuroscience.

[395]  H. Vaudry,et al.  Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[396]  M. Katsura,et al.  Continuous Treatment with Morphine Increases Diazepam Binding Inhibitor mRNA in Mouse Brain , 1998, Journal of neurochemistry.

[397]  H. Vaudry,et al.  Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. , 1998, Journal of medicinal chemistry.

[398]  S. Mandrup,et al.  Inhibition of 3T3-L1 Adipocyte Differentiation by Expression of Acyl-CoA-binding Protein Antisense RNA* , 1998, The Journal of Biological Chemistry.

[399]  M. Baraldi,et al.  Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma. , 1998, Life sciences.

[400]  J. Swinnen,et al.  Identification of Diazepam-binding Inhibitor/Acyl-CoA-binding Protein as a Sterol Regulatory Element-binding Protein-responsive Gene* , 1998, The Journal of Biological Chemistry.

[401]  László Polgár,et al.  Prolyl Oligopeptidase An Unusual β-Propeller Domain Regulates Proteolysis , 1998, Cell.

[402]  J. Benson,et al.  Pharmacology of recombinant γ‐aminobutyric acidA receptors rendered diazepam‐insensitive by point‐mutated α‐subunits , 1998 .

[403]  S. Kulkarni,et al.  The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice , 1998, Psychopharmacology.

[404]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[405]  H. Vaudry,et al.  The Octadecaneuropeptide ODN Induces Anxiety in Rodents: Possible Involvement of a Shorter Biologically Active Fragment , 1998, Peptides.

[406]  D. Aunis,et al.  Antibacterial Peptides Are Present in Chromaffin Cell Secretory Granules , 1998, Cellular and Molecular Neurobiology.

[407]  K. Kuriyama,et al.  [Functional involvement of diazepam binding inhibitor (DBI) in the establishment of drug dependence]. , 1998, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.

[408]  K. Kuriyama,et al.  Continuous treatment with nicotine increases diazepam binding inhibitor (DBI) and its mRNA in the mouse brain. , 1998, Brain research. Molecular brain research.

[409]  M. Gavish,et al.  Effects of Peripheral-type Benzodiazepine Receptor Antisense Knockout on MA-10 Leydig Cell Proliferation and Steroidogenesis* , 1998, The Journal of Biological Chemistry.

[410]  G. Pelletier,et al.  Influence of Adrenal Glands on the Modulation of Prolactin Gene Expression by the Endogenous Benzodiazepine Ligand Octadecaneuropeptide in the Male Rat Pituitary Gland , 1998, Journal of neuroendocrinology.

[411]  O. Lesouhaitier,et al.  Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland. , 1998, Journal of molecular endocrinology.

[412]  H. Kettenmann,et al.  Functional GABAA receptors on human glioma cells , 1998, The European journal of neuroscience.

[413]  J. Swinnen,et al.  Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[414]  L. Niles,et al.  Sensitization of G Protein‐Coupled Benzodiazepine Receptors in the Striatum of 6‐Hydroxydopamine‐Lesioned Rats , 1997, Journal of neurochemistry.

[415]  E. Sigel,et al.  The benzodiazepine binding site of GABAA receptors. , 1997, Trends in pharmacological sciences.

[416]  L. Cazin,et al.  Multiple Modulatory Effects of the Neuroactive Steroid Pregnanolone on GABAA Receptor in Frog Pituitary Melanotrophs , 1997, The Journal of physiology.

[417]  E. Sigel,et al.  A point mutation in the γ2 subunit of γ-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity , 1997 .

[418]  L. Cazin,et al.  Electrophysiological effects of various neuroactive steroids on the GABA(A) receptor in pituitary melanotrope cells. , 1997, European journal of pharmacology.

[419]  B. Birnir,et al.  Hippocampal GABAAchannel conductance increased by diazepam , 1997, Nature.

[420]  A. A. Yeliseev,et al.  A mammalian mitochondrial drug receptor functions as a bacterial "oxygen" sensor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[421]  H. Vaudry,et al.  The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. , 1997, European journal of pharmacology.

[422]  M. Snyder,et al.  Cellular distribution, levels, and function of the diazepam-binding inhibitor/acyl-CoA-binding protein in last instar Manduca sexta midgut , 1997, Cell and Tissue Research.

[423]  K. McCarthy,et al.  ASTROCYTIC NEUROTRANSMITTER RECEPTORS IN SITU AND IN VIVO , 1997, Progress in Neurobiology.

[424]  E. Costa,et al.  Full-length and N-terminally truncated chicken intestinal diazepam-binding inhibitor purification, structural characterization and influence on insulin release , 1997, Regulatory Peptides.

[425]  G. Pelletier,et al.  Involvement of Neurosteroids in the Effect of the Endogenous Benzodiazepine Receptor Ligand Octadecaneuropeptide (ODN) on Gonadotropin‐Releasing Hormone Gene Expression in Rat Brain , 1997, Journal of neuroendocrinology.

[426]  S. Mandrup,et al.  Regulating Adipogenesis* , 1997, The Journal of Biological Chemistry.

[427]  Douglas K. Miller,et al.  The role of the Caspase family of cysteine proteases in apoptosis. , 1997, Seminars in immunology.

[428]  R. Schwartz-Bloom,et al.  Inhibition of GABA-gated Chloride Channels in Brain by the Arachidonic Acid Metabolite, Thromboxane A2 , 1996, Neuropharmacology.

[429]  J. Bénavidès,et al.  Enhanced expression of the peripheral benzodiazepine receptor (PBR) and its endogenous ligand octadecaneuropeptide (ODN) in the regenerating adult rat sciatic nerve , 1996, Neuroscience Letters.

[430]  B. Kragelund,et al.  Thermodynamics of ligand binding to acyl-coenzyme A binding protein studied by titration calorimetry. , 1996, Biochemistry.

[431]  K. Kristiansen,et al.  Regulatory elements in the promoter region of the rat gene encoding the acyl-CoA-binding protein. , 1996, Gene.

[432]  K. Kristiansen,et al.  Disruption of the Gene Encoding the Acyl-CoA-binding Protein (ACB1) Perturbs Acyl-CoA Metabolism in Saccharomyces cerevisiae* , 1996, The Journal of Biological Chemistry.

[433]  L. Niles,et al.  PK 11195 blockade of benzodiazepine‐induced inhibition of forskolin‐stimulated adenylate cyclase activity in the striatum , 1996, British journal of pharmacology.

[434]  C. Nemeroff,et al.  Cerebrospinal Fluid Concentrations of Corticotropin-Releasing Hormone (CRH) and Diazepam-Binding Inhibitor (DBI) during Alcohol Withdrawal and Abstinence , 1996, Neuropsychopharmacology.

[435]  K. Herzig,et al.  Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[436]  J. Swinnen,et al.  Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the rat , 1996, Molecular and Cellular Endocrinology.

[437]  H. Vaudry,et al.  The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes. , 1996, Brain research. Molecular brain research.

[438]  F. Claessens,et al.  A human gene encoding diazepam-binding inhibitor/acy1-CoA-binding protein: transcription and hormonal regulation in the androgen-sensitive human prostatic adenocarcinoma cell line LNCaP. , 1996, DNA and cell biology.

[439]  O. Lesouhaitier,et al.  Localization of diazepam-binding inhibitor-related peptides and peripheral type benzodiazepine receptors in the frog adrenal gland , 1996, Cell and Tissue Research.

[440]  F M Poulsen,et al.  Fast and one-step folding of closely and distantly related homologous proteins of a four-helix bundle family. , 1996, Journal of molecular biology.

[441]  D. Aunis,et al.  The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. , 1996, European journal of biochemistry.

[442]  K. Kuriyama,et al.  Ethanol stimulates diazepam binding inhibitor (DBI) mRNA expression in primary cultured neurons. , 1995, Brain research. Molecular brain research.

[443]  P. Whiting,et al.  beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. , 1995, Molecular pharmacology.

[444]  K. Fuxe,et al.  Intercellular communication in the brain: Wiring versus volume transmission , 1995, Neuroscience.

[445]  S. Pande,et al.  Effects of high-fat diet and fasting on levels of acyl-coenzyme A binding protein in liver, kidney, and heart of rat. , 1995, Metabolism: clinical and experimental.

[446]  D. Baer,et al.  Comparison of effects of adrenalectomy and RU-486 in rats given a choice of maintenance diet and fat supplement. , 1995, The American journal of physiology.

[447]  A. Aguzzi,et al.  Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[448]  G. Pelletier,et al.  Inhibitory effect of the potential endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), on gonadotropin-releasing hormone gene expression in the male rat brain. , 1995, Neuroreport.

[449]  J. Kononen,et al.  Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. , 1995, Cancer research.

[450]  K. Kuriyama,et al.  Increase of diazepam binding inhibitor mRNA levels in the brains of chronically ethanol-treated and -withdrawn mice. , 1995, The Journal of pharmacology and experimental therapeutics.

[451]  F M Poulsen,et al.  Folding of a four-helix bundle: studies of acyl-coenzyme A binding protein. , 1995, Biochemistry.

[452]  K. Tsutsui,et al.  Avian neurosteroids. I. Pregnenolone biosynthesis in the quail brain , 1995, Brain Research.

[453]  A. Guidotti,et al.  Inhibitory effect of ODN, a naturally occurring processing product of diazepam binding inhibitor, on secretagogues-induced insulin secretion , 1995, Regulatory Peptides.

[454]  H. Vaudry,et al.  The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes , 1995, FEBS letters.

[455]  H. Kettenmann,et al.  GABAA/benzodiazepine receptors in acutely isolated hippocampal astrocytes , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[456]  H. Fyrst,et al.  Detection of acyl-CoA-binding protein in human red blood cells and investigation of its role in membrane phospholipid renewal. , 1995, The Biochemical journal.

[457]  D. D. McKinley,et al.  Interaction of β‐carboline inverse agonists for the benzodiazepine site with another site on GABAA receptors , 1995, British journal of pharmacology.

[458]  H. Alho,et al.  Increased expression of diazepam binding inhibitor in human brain tumors. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[459]  V. Gersuk,et al.  Molecular cloning and chromosomal localization of a pseudogene related to the human acyl-CoA binding protein/diazepam binding inhibitor. , 1995, Genomics.

[460]  C. Nemeroff,et al.  Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. , 1994, Alcoholism, clinical and experimental research.

[461]  F. Poulsen,et al.  Comparison of backbone dynamics of apo- and holo-acyl-coenzyme A binding protein using 15N relaxation measurements. , 1994, Biochemistry.

[462]  H. Vaudry,et al.  Localization of diazepam-binding inhibitor and peripheral type benzodiazepine binding sites in the rat ovary , 1994, Anatomy and Embryology.

[463]  F. Labrie,et al.  Immunocytochemical Localization of 5α-Reductase in Rat Brain , 1994, Molecular and Cellular Neuroscience.

[464]  A. Fournier,et al.  Role of neuropeptide Y in the regulation of gonadotropin-releasing hormone gene expression in the rat preoptic area. , 1994, Brain research. Molecular brain research.

[465]  H. Alho,et al.  Tissue-specific expression of the diazepam-binding inhibitor in Drosophila melanogaster: cloning, structure, and localization of the gene , 1994, Molecular and cellular biology.

[466]  V. Papadopoulos,et al.  The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. , 1994, The Journal of biological chemistry.

[467]  K. Kristiansen,et al.  Yeast acyl-CoA-binding protein: acyl-CoA-binding affinity and effect on intracellular acyl-CoA pool size. , 1994, The Biochemical journal.

[468]  J. Davis,et al.  Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels. , 1994, Biochemical pharmacology.

[469]  B. Ahrén,et al.  Inhibition by rat diazepam-binding inhibitor/acyl-CoA-binding protein of glucose-induced insulin secretion in the rat. , 1994, European Journal of Endocrinology.

[470]  H. Vaudry,et al.  Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[471]  A. Guidotti,et al.  The pharmacology of neurosteroidogenesis , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[472]  M. Pestarino.  A Possible Immunomodulatory Role of Endozepine‐like Peptides in a Tunicate a , 1994, Annals of the New York Academy of Sciences.

[473]  J. Simard,et al.  Localization of 3β-Hydroxysteroid Dehydrogenase in Rat Brain as Studied by in Situ Hybridization , 1994, Molecular and Cellular Neuroscience.

[474]  K. Kuriyama,et al.  Nicotine increases diazepam binding inhibitor (DBI) mRNA in primary cultured neurons , 1994, Neuroscience Letters.

[475]  John K. Young.  Immunoreactivity for diazepam binding inhibitor in Gomori-positive astrocytes , 1994, Regulatory Peptides.

[476]  H. Sontheimer,et al.  Fibrous and protoplasmic astrocytes express GABAA receptors that differ in benzodiazepine pharmacology , 1994, Brain Research.

[477]  B. Martin,et al.  Purification of a novel DBI processing product, DBI39–75, and characterization of its binding site in rat brain , 1994, Regulatory Peptides.

[478]  Z. Vidnyánszky,et al.  Diazepam binding inhibitor fragment 33–50 (octadecaneuropeptide) immunoreactivity in the cerebellar cortex is restricted to glial cells , 1994, Glia.

[479]  V. Papadopoulos,et al.  In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. , 1994, Molecular pharmacology.

[480]  I. Appollonio,et al.  Benzodiazepine receptors and diazepam binding inhibitor: A possible link between stress, anxiety and the immune system , 1993, Psychoneuroendocrinology.

[481]  H. Vaudry,et al.  Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain , 1993, Neuroscience.

[482]  H. Alho,et al.  Expression of diazepam-binding inhibitor peptide in human skin: an immunohistochemical and ultrastructural study. , 1993, The Journal of investigative dermatology.

[483]  P. Ferrara,et al.  A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. , 1993, Journal of molecular graphics.

[484]  A. Guidotti,et al.  Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex. , 1993, The Journal of pharmacology and experimental therapeutics.

[485]  E. Costa,et al.  Cloning and tissue-specific functional characterization of the promoter of the rat diazepam binding inhibitor, a peptide with multiple biological actions. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[486]  V. Mutt,et al.  Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910. , 1993, European journal of biochemistry.

[487]  A. Stanisz,et al.  Immunomodulatory properties of diazepam-binding inhibitor: Effect on human interleukin-6 secretion, lymphocyte proliferation and natural killer cell activity in vitro , 1993, Neuropeptides.

[488]  M. Snyder,et al.  A diazepam binding inhibitor (DBI) homolog from the tobacco hornworm, Manduca sexta , 1993, Molecular and Cellular Endocrinology.

[489]  V. Papadopoulos,et al.  Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[490]  J. Knudsen,et al.  Interaction of acyl-CoA binding protein (ACBP) on processes for which acyl-CoA is a substrate, product or inhibitor. , 1993, The Biochemical journal.

[491]  K. Kristiansen,et al.  The function of acyl-CoA-binding protein (ACBP)/Diazepam binding inhibitor (DBI) , 1993, Molecular and Cellular Biochemistry.

[492]  P. Eriksson,et al.  GABA induces Ca2+ transients in astrocytes , 1993, Neuroscience.

[493]  F M Poulsen,et al.  Three-dimensional structure of the complex between acyl-coenzyme A binding protein and palmitoyl-coenzyme A. , 1993, Journal of molecular biology.

[494]  V. Papadopoulos.  Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. , 1993, Endocrine reviews.

[495]  J. Knudsen,et al.  Characterization of ligand binding to acyl-CoA-binding protein. , 1993, The Biochemical journal.

[496]  K. Kristiansen,et al.  Effect of heterologous expression of acyl-CoA-binding protein on acyl-CoA level and composition in yeast. , 1993, The Biochemical journal.

[497]  K. Kristiansen,et al.  Acyl-CoA-binding protein/diazepam-binding inhibitor gene and pseudogenes. A typical housekeeping gene family. , 1992, Journal of molecular biology.

[498]  T. Rose,et al.  Molecular cloning of the gene for the yeast homolog (ACB) of diazepam binding inhibitor/endozepine/acyl-CoA-binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[499]  H. Vaudry,et al.  Characterization of endozepine-related peptides in the central nervous system and in peripheral tissues of the rat , 1992, Peptides.

[500]  J. Ballenger,et al.  CSF diazepam-binding inhibitor concentrations in panic disorder , 1992, Biological Psychiatry.

[501]  V. Papadopoulos,et al.  Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex , 1992, Molecular and Cellular Endocrinology.

[502]  F. Poulsen,et al.  Three-dimensional structure in solution of acyl-coenzyme A binding protein from bovine liver. , 1992, Journal of molecular biology.

[503]  P. Skolnick,et al.  The human "peripheral-type" benzodiazepine receptor: regional mapping of the gene and characterization of the receptor expressed from cDNA. , 1992, DNA and cell biology.

[504]  S. Naylor,et al.  New chromosomal mapping assignments for argininosuccinate synthetase pseudogene 1, interferon-β3 gene, and the diazepam binding inhibitor gene , 1992, Somatic cell and molecular genetics.

[505]  A. Guidotti,et al.  Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[506]  H. Alho,et al.  Expression of diazepam binding inhibitor-like immunoreactivity in rat testis is dependent on pituitary hormones. , 1992, Endocrinology.

[507]  C. Launo,et al.  [Clinical evaluation of pre-surgical anxiety: changes in plasma levels of the anxiety peptide (diazepam binding inhibitor)]. , 1992, Minerva Anestesiologica.

[508]  A. Allan,et al.  Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels. , 1992, The Journal of pharmacology and experimental therapeutics.

[509]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[510]  H. Vaudry,et al.  Localization and characterization of diazepam-binding inhibitor (DBI)-like peptides in the brain and pituitary of the trout (Salmo gairdneri) , 1992, Brain Research.

[511]  M. Majewska,et al.  Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance , 1992, Progress in Neurobiology.

[512]  P. Cornu,et al.  Increase in ω3 (Peripheral-Type Benzodiazepine) binding site densities in different types of human brain tumours , 1992, Acta Neurochirurgica.

[513]  S. Paul.  NEUROACTIVE STEROIDS , 1992, Pediatric Research.

[514]  I. Ashmarin,et al.  [Increase of seizure threshold and resistance to stress in rats after immunization against fragment of diazepam-binding inhibitor]. , 1992, Biulleten' eksperimental'noi biologii i meditsiny.

[515]  K. Kultas‐Ilinsky,et al.  Diazepam binding inhibitor processing in the rhesus monkey brain: An immunocytochemical study , 1992, Journal of Chemical Neuroanatomy.

[516]  H. Vaudry,et al.  Distribution and characterization of endozepine-like immunoreactivity in the central nervous system of the frog Rana ridibunda , 1992, Peptides.

[517]  V. Papadopoulos,et al.  Endozepine/diazepam binding inhibitor in adrenocortical and Leydig cell lines: Absence of hormonal regulation , 1992, Molecular and Cellular Endocrinology.

[518]  P. Seeburg,et al.  A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. , 1992, The Journal of biological chemistry.

[519]  C. Östenson,et al.  Diazepam binding inhibitor and the endocrine pancreas , 1991, Neuropharmacology.

[520]  H. Alho,et al.  Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: Its possible role as an endogenous regulator of different types of benzodiazepine receptors , 1991, Neuropharmacology.

[521]  P. D. Stefanis,et al.  Modulation of insulin secretion by diazepam binding inhibitor and its processing products , 1991, Neuropharmacology.

[522]  A. Guidotti.  Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior , 1991, Neuropharmacology.

[523]  S. Mandrup,et al.  The secondary structure in solution of acyl-coenzyme A binding protein from bovine liver using 1H nuclear magnetic resonance spectroscopy. , 1991, Biochemistry.

[524]  P. Hall,et al.  Stimulation by endozepine of the side-chain cleavage of cholesterol in a reconstituted enzyme system. , 1991, Biochemical and biophysical research communications.

[525]  A. Vezzani,et al.  Epileptogenic Activity of Two Peptides Derived from Diazepam Binding Inhibitor After Intrahippocampal Injection in Rats , 1991, Epilepsia.

[526]  H. Vaudry,et al.  Distribution and characterization of endogenous benzodiazepine receptor ligand (endozepine)-like peptides in the rat gastrointestinal tract. , 1991, Endocrinology.

[527]  A. Guidotti,et al.  Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. , 1991, Endocrinology.

[528]  S. Efendić,et al.  Porcine diazepam-binding inhibitor is immunohistochemically colocalized with somatostatin in the D cells of human and porcine gastrointestinal tract and in pancreatic islet cells , 1991, Endocrine Pathology.

[529]  G. Pelletier,et al.  Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization , 1991, Neuropeptides.

[530]  A. Guidotti,et al.  Regulation of diazepam binding inhibitor in rat adrenal gland by adrenocorticotropin. , 1991, Endocrinology.

[531]  F. Labrie.  Intracrinology , 1991, Molecular and Cellular Endocrinology.

[532]  J. Regan,et al.  Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein. , 1991, The Journal of biological chemistry.

[533]  K. Kristiansen,et al.  Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiation. , 1991, The Biochemical journal.

[534]  H. Vaudry,et al.  Quantitative evaluation of octadecaneuropeptide-like immunoreactivity in hippocampus, cortex and cerebellum of long-term isolated male Wistar rats , 1991, Neuropeptides.

[535]  J. Simard,et al.  Localization of peripheral benzodiazepine binding sites and diazepam-binding inhibitor (DBI) mRNA in mammary glands and dimethylbenz(α)antracene (DMBA)-induced mammary tumors in the rat , 1991, Regulatory Peptides.

[536]  B. Descamps-Latscha,et al.  Endogenous anxiogenic peptide, ODN-diazepam-binding inhibitor, and benzodiazepines enhance the production of interleukin-1 and tumor necrosis factor by human monocytes. , 1991, Lymphokine and cytokine research.

[537]  R. Butterworth,et al.  Increased brain content of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), following portacaval anastomosis in the rat , 1991, Peptides.

[538]  V. Papadopoulos,et al.  Hormone-stimulated steroidogenesis is coupled to mitochondrial benzodiazepine receptors. Tropic hormone action on steroid biosynthesis is inhibited by flunitrazepam. , 1991, The Journal of biological chemistry.

[539]  E. Korneva,et al.  Acetylcholinesterase activity of rat lymphosides during pesticide poisoning , 1991, Bulletin of Experimental Biology and Medicine.

[540]  V. Mutt,et al.  Immunohistochemical localization of porcine diazepam-binding inhibitor (DBI) to rat endocrine pancreas , 1991, Cell and Tissue Research.

[541]  J. Hoffman,et al.  Flumazenil: a new benzodiazepine antagonist. , 1991 .

[542]  L. Niles,et al.  Pharmacological inhibition of forskolin-stimulated adenylate cyclase activity in rat brain by melatonin, its analogs, and diazepam. , 1990, Biochemical pharmacology.

[543]  P. Højrup,et al.  Determination by photoaffinity labelling of the hydrophobic part of the binding site for acyl-CoA esters on acyl-CoA-binding protein from bovine liver. , 1990, The Biochemical journal.

[544]  J. Simard,et al.  Localization of the endogenous benzodiazepine ligand octadecaneuropeptide in the rat testis. , 1990, Endocrinology.

[545]  D. Nutt,et al.  Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. , 1990, Archives of general psychiatry.

[546]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. , 1990, The Journal of biological chemistry.

[547]  D Levitt,et al.  Gramicidin, VDAC, porin and perforin channels. , 1990, Current opinion in cell biology.

[548]  A. Guidotti,et al.  Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat , 1990, Regulatory Peptides.

[549]  C. Östenson,et al.  Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas , 1990, Regulatory Peptides.

[550]  B. Descamps-Latscha,et al.  Altered expression of neutrophil peripheral benzodiazepine receptor in X-linked chronic granulomatous disease. , 1990, Blood.

[551]  A. Guidotti,et al.  A study of diazepam binding inhibitor (DBI) processing products in human cerebrospinal fluid and in postmortem human brain , 1990, Neuropharmacology.

[552]  G. Pelletier,et al.  Localization of the Endogenous Benzodiazepine Receptor Ligand Octadecaneuropeptide and Peripheral Type Benzodiazepine Receptors in the Rat Pituitary , 1990, Journal of neuroendocrinology.

[553]  F. Tamma,et al.  Cerebrospinal fluid levels of diazepam‐binding inhibitor in neurodegenerative disorders with dementia , 1990, Neurology.

[554]  A. Guidotti,et al.  CSF diazepam-binding inhibitor in alcoholics and normal controls , 1990, Psychiatry Research.

[555]  A. Guidotti,et al.  A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes. , 1990, Molecular pharmacology.

[556]  M. Gavish,et al.  Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. , 1990, Clinical science.

[557]  J. Knudsen,et al.  Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. , 1990, The Biochemical journal.

[558]  H. Vaudry,et al.  Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain , 1990, Neuropeptides.

[559]  L. Cazin,et al.  Central-type benzodiazepines and the octadecaneuropeptide modulate the effects of GABA on the release of α-melanocyte-stimulating hormone from frog neurointermediate lobe in vitro , 1989, Neuroscience.

[560]  J. Medina,et al.  Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. , 1989, Biochemical and biophysical research communications.

[561]  M. Santi,et al.  Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. , 1989, The Journal of biological chemistry.

[562]  J. Sikela,et al.  Sequence and expression of the murine diazepam binding inhibitor. , 1989, Brain research. Molecular brain research.

[563]  A. Guidotti,et al.  Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain. , 1989, Journal of chemical neuroanatomy.

[564]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[565]  A. Guidotti,et al.  Isolation and Characterization of a Rat Brain Triakontatetraneuropeptide, a Posttranslational Product of Diazepam Binding Inhibitor: Specific Action at the Ro 5‐4864 Recognition Site , 1989, Journal of neurochemistry.

[566]  E. Baulieu,et al.  Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. , 1989, Endocrinology.

[567]  I. Appollonio,et al.  Benzodiazepine receptors and diazepam‐binding inhibitor in human cerebral tumors , 1989, Annals of neurology.

[568]  A. Guidotti,et al.  Diazepam‐binding inhibitor and corticotropin‐releasing hormone in cerebrospinal fluid , 1989 .

[569]  P. Højrup,et al.  Acyl-CoA-binding protein in the rat. Purification, binding characteristics, tissue concentrations and amino acid sequence. , 1989, The Biochemical journal.

[570]  U. Klotz,et al.  Detection of desmethyldiazepam and diazepam in brain of different species and plants. , 1989, Biochemical pharmacology.

[571]  A. Guidotti,et al.  Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy , 1989, Annals of neurology.

[572]  T D Lee,et al.  Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[573]  D. Freeman.  Plasma membrane cholesterol: removal and insertion into the membrane and utilization as substrate for steroidogenesis. , 1989, Endocrinology.

[574]  P. Ferrara,et al.  Characterization of a peripheral‐type benzodiazepine‐binding site in the mitochondria of Chinese hamster ovary cells , 1989, FEBS letters.

[575]  F. Tamma,et al.  Distribution of a putative endogenous modulator of the GABA ergic system in human brain , 1989, Neurology.

[576]  Stephen R. Bloom,et al.  Diazepam binding inhibitor-like immunoreactivity(51–70): distribution in human brain, spinal cord and peripheral tissues , 1989, Brain Research.

[577]  S. Snyder,et al.  Characterization of porphyrin interactions with peripheral type benzodiazepine receptors. , 1988, Molecular pharmacology.

[578]  A. Guidotti,et al.  Purification and characterization of a protein associated with peripheral-type benzodiazepine binding sites. , 1988, The Journal of biological chemistry.

[579]  R. Maurer,et al.  Occurrence of pharmacologically active benzodiazepines in trace amounts in wheat and potato. , 1988, Biochemical pharmacology.

[580]  K. Yanagibashi,et al.  The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. , 1988, Endocrinology.

[581]  E. Costa,et al.  Diazepam binding inhibitor gene expression: location in brain and peripheral tissues of rat. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[582]  R. Eddy,et al.  Chromosomal localization of the human diazepam binding inhibitor gene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[583]  R. Maurer,et al.  Diazepam and N-desmethyldiazepam are found in rat brain and adrenal and may be of plant origin , 1988, Journal of Neural Transmission.

[584]  V. Mutt,et al.  Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. , 1988, European journal of biochemistry.

[585]  J. Medina,et al.  Proconvulsant and ‘anxiogenic’ effects of n-butyl β carboline-3-carboxylate, an endogenous benzodiazepine binding inhibitor from brain , 1988, Pharmacology Biochemistry and Behavior.

[586]  J. Medina,et al.  Presence of benzodiazepine-like molecules in mammalian brain and milk. , 1988, Biochemical and biophysical research communications.

[587]  K. Beaumont,et al.  Photoaffinity labeling of peripheral-type benzodiazepine receptors in rat kidney mitochondria with [3H]PK 14105. , 1988, European journal of pharmacology.

[588]  W. Haefely.  Endogenous Ligands of the Benzodiazepine Receptor , 1988, Pharmacopsychiatry.

[589]  J. Mikkelsen,et al.  Acyl-CoA-binding protein from cow. Binding characteristics and cellular and tissue distribution. , 1987, The Biochemical journal.

[590]  P. Højrup,et al.  Amino acid sequence of acyl-CoA-binding protein from cow liver. , 1987, The Biochemical journal.

[591]  J. Kardos,et al.  GABAA receptor-controlled 36Cl- influx in cultured rat cerebellar granule cells. , 1987, Life sciences.

[592]  P. Seeburg,et al.  Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family , 1987, Nature.

[593]  A. Guidotti,et al.  Co-localization and co-release of GABA and putative allosteric modulators of GABA receptor , 1987, Neuropharmacology.

[594]  P. Gray.  Molecular biology of diazepam binding inhibitor , 1987, Neuropharmacology.

[595]  Dongeun Park,et al.  Endogenous benzodiazepine-like molecules in the human, rat and bovine brains studied with a monoclonal antibody to benzodiazepines , 1987, Brain Research.

[596]  S H Snyder,et al.  Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[597]  A. Guidotti,et al.  Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[598]  T. Rose,et al.  Bovine and human cDNA sequences encoding a putative benzodiazepine receptor ligand. , 1987, DNA.

[599]  L. Hertz,et al.  Octadecaneuropeptide (ODN; 'anxiety peptide') displaces diazepam more potently from astrocytic than from neuronal binding sites. , 1986, European journal of pharmacology.

[600]  S. Bloom,et al.  Octadecaneuropeptide, benzodiazepine ligand, -like immunoreactivity in rat central nervous system, plasma and peripheral tissues , 1986, Neuroscience Letters.

[601]  A. Guidotti,et al.  A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain , 1986, Brain Research.

[602]  S. Paul,et al.  Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease. , 1986, Archives of general psychiatry.

[603]  H. Fales,et al.  Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[604]  L. Sangameswaran,et al.  Demonstration and purification of an endogenous benzodiazepine from the mammalian brain with a monoclonal antibody to benzodiazepines. , 1986, Life sciences.

[605]  T. Castonguay,et al.  Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. , 1986, The American journal of physiology.

[606]  L. Cazin,et al.  GABA-ergic control of α-Melanocyte-Stimulating Hormone (α-MSH) release by frog neurointermediate lobe in vitro , 1986, Brain Research Bulletin.

[607]  A. Guidotti,et al.  Cloning and expression of cDNA for human diazepam binding inhibitor, a natural ligand of an allosteric regulatory site of the gamma-aminobutyric acid type A receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[608]  J. Brosius,et al.  Putative diazepam binding inhibitor peptide: cDNA clones from rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[609]  M. Kavaliers,et al.  An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice , 1986, Brain Research.

[610]  G. Todaro,et al.  Isolation and characterization of a putative endogenous benzodiazepineoid (endozepine) from bovine and human brain. , 1986, The Journal of biological chemistry.

[611]  G. Todaro,et al.  Complete amino acid sequences of bovine and human endozepines. Homology with rat diazepam binding inhibitor. , 1986, The Journal of biological chemistry.

[612]  J. Medina,et al.  Isolation and identification in bovine cerebral cortex of n-butyl beta-carboline-3-carboxylate, a potent benzodiazepine binding inhibitor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[613]  E. Costa,et al.  Pharmacological modulation of gabaergic transmission in cultured cerebellar neurons , 1986, Neuropharmacology.

[614]  M. Santi,et al.  Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[615]  R. Anholt,et al.  The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.

[616]  J. Slangen,et al.  The Ro 15-1788 cue: evidence for benzodiazepine agonist and inverse agonist properties. , 1985, European journal of pharmacology.

[617]  C. Tanaka,et al.  gamma-Aminobutyric acid in peripheral tissues. , 1985, Life sciences.

[618]  A. Guidotti,et al.  gamma-Aminobutyric acid- and benzodiazepine-induced modulation of [35S]- t-butylbicyclophosphorothionate binding to cerebellar granule cells , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[619]  L. Sangameswaran,et al.  Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[620]  A. Guidotti,et al.  Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. , 1985, Science.

[621]  B. Rolfe,et al.  [3H] diazepam binding to human granulocytes. , 1985, Life Science.

[622]  R. Dingledine,et al.  Reduction of inhibition by a benzodiazepine antagonist, Ro15-1788, in the rat hippocampal slice , 1985, Neuroscience.

[623]  H. Yamamura,et al.  Autoradiographic localization of “peripheral-type” benzodiazepine binding sites in the rat brain, heart and kidney , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[624]  R. Anholt,et al.  Peripheral-type benzodiazepine receptors in the central nervous system: localization to olfactory nerves , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[625]  A. Guidotti,et al.  A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sites , 1984, Neuropharmacology.

[626]  A. Guidotti,et al.  Isolation, purification and partial sequence of a neuropeptide (diazepam-binding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition site , 1984, Neuroscience Letters.

[627]  H. M. Geller,et al.  Electrophysiological studies on benzodiazepine antagonists , 1984, Brain Research.

[628]  S. Rauch,et al.  Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity , 1984, Nature.

[629]  J. Bénavidès,et al.  Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. , 1983, Life sciences.

[630]  A. Guidotti,et al.  Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[631]  H. Schoemaker,et al.  Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. , 1983, The Journal of pharmacology and experimental therapeutics.

[632]  A. Lajtha,et al.  Thyroid Hormones and Derivatives Inhibit Flunitrazepam Binding , 1983, Journal of neurochemistry.

[633]  T. Asano,et al.  Prostaglandins A as possible endogenous ligands of benzodiazepine receptor. , 1982, European journal of pharmacology.

[634]  G. Handelmann,et al.  N-acetylation regulates the behavioral activity of alpha-melanotropin in a multineurotransmitter neuron. , 1982, Science.

[635]  T. Taniguchi,et al.  [3H]Diazepam binding sites on rat heart and kidney. , 1982, Biochemical pharmacology.

[636]  T. O'donohue,et al.  Evidence that N-acetylation regulates the behavioral activity of α-MSH in the rat and human central nervous system , 1981, Peptides.

[637]  K. Koumjian.  The use of valium as a form of social control. , 1981, Social science & medicine. Part E, Medical psychology.

[638]  F. Goodwin,et al.  Inhibition of diazepam binding by tryptophan derivatives including melatonin and its brain metabolite N-acetyl-5-methoxy kynurenamine. , 1981, Life sciences.

[639]  L. Pieri,et al.  Selective antagonists of benzodiazepines , 1981, Nature.

[640]  C. Olsen,et al.  Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[641]  S. Paul,et al.  Receptors for the age of anxiety: pharmacology of the benzodiazepines. , 1980, Science.

[642]  M. Finnie,et al.  Endorphins are stored in biologically active and inactive forms: isolation of α-N-acetyl peptides , 1979, Nature.

[643]  L. Pieri,et al.  Nicotinamide is a brain constituent with benzodiazepine-like actions , 1979, Nature.

[644]  S. Paul,et al.  Inosine, an endogenous ligand of the brain benzodiazepine receptor, antagonizes pentylenetetrazole-evoked seizures. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[645]  S. Spector,et al.  Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine-binding sites. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[646]  A. Guidotti,et al.  An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain , 1978, Nature.

[647]  F. Goodwin,et al.  Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. , 1978, Life sciences.

[648]  A. Guidotti,et al.  Purification of an endogenous protein inhibitor of the high affinity binding of gamma-aminobutyric acid to synaptic membranes of rat brain. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[649]  F. Goodwin,et al.  Demonstration of an endogenous, competitive inhibitor(s) of [3H] diazepam binding in bovine brain. , 1978, Life sciences.

[650]  C. Braestrup,et al.  Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[651]  C. Braestrup,et al.  Benzodiazepine receptors in rat brain , 1977, Nature.

[652]  N. Ling,et al.  beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[653]  H. Morris,et al.  Identification of two related pentapeptides from the brain with potent opiate agonist activity , 1975, Nature.

[654]  K. Ikeda,et al.  Effects of GABA and bicuculline on conductance of crayfish abdominal stretch receptor. , 1973, Nature: New biology.

[655]  N. Ling,et al.  Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone , 1973, Science.

[656]  P. Morselli,et al.  Effect of diazepam on plasma corticosterone levels in the rat , 1969, The Journal of pharmacy and pharmacology.

[657]  W. Leimgruber,et al.  The structure of anthramycin. , 1965, Journal of the American Chemical Society.

[658]  G. A. Heise,et al.  Pharmacological and clinical studies on Valium (T.M.) a new psychotherapeutic agent of the benzodiazepine class. , 1961, Current therapeutic research, clinical and experimental.

[659]  L. Sternbach,et al.  Quinazolines and 1,4-Benzodiazepines. II.1 The Rearrangement of 6-Chloro-2-chloromethyl-4-phenylquinazoline 3-Oxide into 2-Amino Derivatives of 7-Chloro-5-phenyl-3H-1,4-benzodiazepine 4-Oxide , 1961 .

[660]  CCK , 2019, Springer Reference Medizin.

[661]  P. Elustondo,et al.  Mitochondrial cholesterol import. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[662]  Jean Martínez,et al.  Silaproline, a Silicon-Containing Proline Surrogate , 2015 .

[663]  H. Möhler.  The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism. , 2015, Advances in pharmacology.

[664]  W. Sieghart.  Allosteric modulation of GABAA receptors via multiple drug-binding sites. , 2015, Advances in pharmacology.

[665]  U. Rudolph,et al.  Behavioral functions of GABAA receptor subtypes--the Zurich experience. , 2015, Advances in pharmacology.

[666]  J. Huguenard,et al.  Chapter Five - Endozepines , 2015 .

[667]  W. R. Butler,et al.  Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. , 2014, Endocrinology.

[668]  V. Papadopoulos.  On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. , 2014, Endocrinology.

[669]  C. Martini,et al.  Translocator protein (TSPO) and neurosteroids: implications in psychiatric disorders. , 2012, Current molecular medicine.

[670]  E. Sigel,et al.  A closer look at the high affinity benzodiazepine binding site on GABAA receptors. , 2011, Current topics in medicinal chemistry.

[671]  K. Sawaki,et al.  Diazepam Enhances Production of Diazepam-Binding Inhibitor (DBI), a Negative Saliva Secretion Regulator, Localized in Rat Salivary Gland. , 2011, Journal of Pharmacological Sciences.

[672]  D. Byrne,et al.  Chronic administration of methamphetamine increases the mRNA expression of diazepam binding inhibitor in rat brain. , 2008, The Tokai journal of experimental and clinical medicine.

[673]  M. Fleming,et al.  Loss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skin. , 2007, The Journal of investigative dermatology.

[674]  A. Kastin.  Handbook of biologically active peptides , 2006 .

[675]  S. File,et al.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788 , 2004, Psychopharmacology.

[676]  L. Hösli,et al.  Evidence for GABAB-receptors on cultured astrocytes of rat CNS: autoradiographic binding studies , 2004, Experimental Brain Research.

[677]  A. Fietta,et al.  Intracellular calcium changes induced by the endozepine triakontatetraneuropeptide in human polymorphonuclear leukocytes: role of protein kinase C and effect of calcium channel blockers , 2004, Cell Communication and Signaling.

[678]  J. A. Peters,et al.  Neurosteroid modulation of GABAA receptors. , 2003, Progress in neurobiology.

[679]  J. Fritschy,et al.  A new benzodiazepine pharmacology. , 2002, The Journal of pharmacology and experimental therapeutics.

[680]  H. Vaudry,et al.  Biosynthesis of neurosteroids and regulation of their synthesis. , 2001, International review of neurobiology.

[681]  P. Lapchak,et al.  Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. , 2001, International review of neurobiology.

[682]  D. Stocco.  StAR protein and the regulation of steroid hormone biosynthesis. , 2001, Annual review of physiology.

[683]  O. Lesouhaitier,et al.  The Effect of the Endozepine Triakontatetraneuropeptide on Corticosteroid Secretion by the Frog Adrenal Gland Is Mediated by Activation of Adenylyl Cyclase and Calcium Influx through T-Type Calcium Channels1. , 2000, Endocrinology.

[684]  P. Riederer,et al.  Naturally occurring benzodiazepines: current status of research and clinical implications , 2000, European Archives of Psychiatry and Clinical Neuroscience.

[685]  V. Papadopoulos,et al.  Peripheral-Type Benzodiazepine Receptor ( PBR ) in Human Breast Cancer : Correlation of Breast Cancer Cell Aggressive Phenotype with PBR Expression , Nuclear Localization , and PBR-mediated Cell Proliferation and Nuclear Transport of Cholesterol 1 , 1999 .

[686]  K. Ukena,et al.  Cytochrome P450 side-chain cleavage enzyme in the cerebellar Purkinje neuron and its neonatal change in rats. , 1998, Endocrinology.

[687]  I. Salliot-Maire.  Etude structurale par RMN et par modélisation moléculaire de peptides endogènes ligands des récepteurs aux benzodiazépines : l'octadécaneuropeptide (ODN - DBI 33-50) et le triakontatétraneuropeptide (TTN - DBI 17-50) , 1998 .

[688]  V. Papadopoulos,et al.  Peripheral-Type Benzodiazepine Receptor Function in Cholesterol Transport. Identification of a Putative Cholesterol Recognition/Interaction Amino Acid Sequence and Consensus Pattern* * This work was supported by grant number ES-07747 from the National Institute of Environmental Health Sciences, NIH , 1998, Endocrinology.

[689]  H. Alho,et al.  The transcriptional and translational control of diazepam binding inhibitor expression in rat male germ-line cells. , 1997, DNA and cell biology.

[690]  E. Baulieu.  Neurosteroids: of the nervous system, by the nervous system, for the nervous system. , 1997, Recent progress in hormone research.

[691]  J. Gogusev,et al.  Modulation of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, interleukin-8, and granulocyte/macrophage colony-stimulating factor expression in human monocytes by an endogenous anxiogenic benzodiazepine ligand, triakontatetraneuropeptide: evidence for a role of prostaglandins. , 1993, Molecular pharmacology.

[692]  V. Papadopoulos,et al.  Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. , 1993, Endocrinology.

[693]  U. Klotz.  Occurrence of "natural" benzodiazepines. , 1991, Life sciences.

[694]  A. Guidotti,et al.  Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. , 1991, Life sciences.

[695]  M. Mattei,et al.  Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. , 1991, European journal of biochemistry.

[696]  I. Zhdanova,et al.  [Changes in the emotionally conditioned behavior of rats under the influence of the hexapeptide fragment GLLDLK of the protein inhibitor of diazepam binding]. , 1991, Biulleten' eksperimental'noi biologii i meditsiny.

[697]  T. Matsui,et al.  Peripheral-type benzodiazepine receptors are involved in the regulation of cholesterol side chain cleavage in adrenocortical mitochondria. , 1989, Journal of biochemistry.

[698]  I. Falconer,et al.  Toxicity of the cyanobacterium Nodularia spumigena Mertens. , 1988, Toxicon : official journal of the International Society on Toxinology.

[699]  T. Kurokawa,et al.  Inhibition of rat brain adenylate cyclase activity by benzodiazepine through the effects on Gi and catalytic proteins. , 1988, Life sciences.

[700]  G. Le Fur,et al.  Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. , 1987, Molecular pharmacology.

[701]  F. Spener,et al.  A novel acyl-CoA-binding protein from bovine liver. Effect on fatty acid synthesis. , 1987, The Biochemical journal.

[702]  A. Guidotti,et al.  DBI, an anxiogenic neuropeptide found in human brain. , 1986, Advances in biochemical psychopharmacology.

[703]  J. Medina,et al.  Identification of a potent endogenous benzodiazepine binding inhibitor from bovine cerebral cortex. , 1986, Advances in biochemical psychopharmacology.

[704]  R. Gross,et al.  Benzodiazepine, beta-carboline, and barbiturate actions on GABA responses. , 1986, Advances in biochemical psychopharmacology.

[705]  J. Veerkamp,et al.  Intracellular fatty acid-binding proteins. , 1985, The International journal of biochemistry.

[706]  A. Guidotti,et al.  Neuropeptide modulation of GABA receptor C1- channels. , 1985, Regulatory peptides. Supplement.

[707]  M. Luckner,et al.  Enzymatic synthesis of cyclopeptine intermediates in Penicillium cyclopium , 1985 .

[708]  L. Sternbach.  The benzodiazepine story. , 1983, Journal of psychoactive drugs.

[709]  W. Haefely.  Antagonists of benzodiazepines. , 1983, L'Encephale.

[710]  Y. Kumahara,et al.  [TRH]. , 1982, Nihon rinsho. Japanese journal of clinical medicine.

[711]  G. Waller,et al.  12 – Enzymology of Alkaloid Metabolism in Plants and Microorganisms , 1981 .

[712]  R. Nishioka,et al.  Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.